averaged GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
ESRRA
|
ENSG00000173153.9 | estrogen related receptor alpha |
ESR2
|
ENSG00000140009.14 | estrogen receptor 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
ESR2 | hg19_v2_chr14_-_64761078_64761128 | 0.37 | 1.9e-08 | Click! |
ESRRA | hg19_v2_chr11_+_64073699_64073918 | 0.31 | 2.1e-06 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr14_-_106174960 | 137.89 |
ENST00000390547.2
|
IGHA1
|
immunoglobulin heavy constant alpha 1 |
chr22_+_23237555 | 101.06 |
ENST00000390321.2
|
IGLC1
|
immunoglobulin lambda constant 1 (Mcg marker) |
chr22_+_23248512 | 100.61 |
ENST00000390325.2
|
IGLC3
|
immunoglobulin lambda constant 3 (Kern-Oz+ marker) |
chr22_+_23243156 | 91.62 |
ENST00000390323.2
|
IGLC2
|
immunoglobulin lambda constant 2 (Kern-Oz- marker) |
chr14_-_106209368 | 90.70 |
ENST00000390548.2
ENST00000390549.2 ENST00000390542.2 |
IGHG1
|
immunoglobulin heavy constant gamma 1 (G1m marker) |
chr14_-_106054659 | 86.73 |
ENST00000390539.2
|
IGHA2
|
immunoglobulin heavy constant alpha 2 (A2m marker) |
chr22_+_23264766 | 74.03 |
ENST00000390331.2
|
IGLC7
|
immunoglobulin lambda constant 7 |
chr22_+_23241661 | 61.89 |
ENST00000390322.2
|
IGLJ2
|
immunoglobulin lambda joining 2 |
chr22_+_23247030 | 61.15 |
ENST00000390324.2
|
IGLJ3
|
immunoglobulin lambda joining 3 |
chr22_+_23229960 | 58.05 |
ENST00000526893.1
ENST00000532223.2 ENST00000531372.1 |
IGLL5
|
immunoglobulin lambda-like polypeptide 5 |
chr6_+_33043703 | 57.05 |
ENST00000418931.2
ENST00000535465.1 |
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1 |
chr16_+_222846 | 54.47 |
ENST00000251595.6
ENST00000397806.1 |
HBA2
|
hemoglobin, alpha 2 |
chr14_-_106237742 | 49.22 |
ENST00000390551.2
|
IGHG3
|
immunoglobulin heavy constant gamma 3 (G3m marker) |
chr14_-_106330072 | 46.52 |
ENST00000488476.1
|
IGHJ5
|
immunoglobulin heavy joining 5 |
chr14_-_106322288 | 40.32 |
ENST00000390559.2
|
IGHM
|
immunoglobulin heavy constant mu |
chr6_-_167369612 | 38.92 |
ENST00000507747.1
|
RP11-514O12.4
|
RP11-514O12.4 |
chr11_+_67033881 | 38.90 |
ENST00000308595.5
ENST00000526285.1 |
ADRBK1
|
adrenergic, beta, receptor kinase 1 |
chr6_-_32498046 | 38.72 |
ENST00000374975.3
|
HLA-DRB5
|
major histocompatibility complex, class II, DR beta 5 |
chr2_+_85804614 | 37.47 |
ENST00000263864.5
ENST00000409760.1 |
VAMP8
|
vesicle-associated membrane protein 8 |
chr14_-_106642049 | 32.32 |
ENST00000390605.2
|
IGHV1-18
|
immunoglobulin heavy variable 1-18 |
chr19_+_1065922 | 32.03 |
ENST00000539243.2
|
HMHA1
|
histocompatibility (minor) HA-1 |
chr19_-_36399149 | 29.77 |
ENST00000585901.2
ENST00000544690.2 ENST00000424586.3 ENST00000262629.4 ENST00000589517.1 |
TYROBP
|
TYRO protein tyrosine kinase binding protein |
chr14_-_24911868 | 27.49 |
ENST00000554698.1
|
SDR39U1
|
short chain dehydrogenase/reductase family 39U, member 1 |
chr22_-_17680472 | 27.16 |
ENST00000330232.4
|
CECR1
|
cat eye syndrome chromosome region, candidate 1 |
chr7_-_150498426 | 26.96 |
ENST00000447204.2
|
TMEM176B
|
transmembrane protein 176B |
chr22_+_23040274 | 26.92 |
ENST00000390306.2
|
IGLV2-23
|
immunoglobulin lambda variable 2-23 |
chr14_-_94856987 | 26.90 |
ENST00000449399.3
ENST00000404814.4 |
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
chr2_-_89310012 | 26.86 |
ENST00000493819.1
|
IGKV1-9
|
immunoglobulin kappa variable 1-9 |
chr14_-_94857004 | 26.84 |
ENST00000557492.1
ENST00000448921.1 ENST00000437397.1 ENST00000355814.4 ENST00000393088.4 |
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
chr19_-_39826639 | 26.30 |
ENST00000602185.1
ENST00000598034.1 ENST00000601387.1 ENST00000595636.1 ENST00000253054.8 ENST00000594700.1 ENST00000597595.1 |
GMFG
|
glia maturation factor, gamma |
chr4_+_668348 | 26.08 |
ENST00000511290.1
|
MYL5
|
myosin, light chain 5, regulatory |
chr19_+_42381173 | 25.95 |
ENST00000221972.3
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha |
chr19_+_1041212 | 25.45 |
ENST00000433129.1
|
ABCA7
|
ATP-binding cassette, sub-family A (ABC1), member 7 |
chr21_-_46330545 | 25.18 |
ENST00000320216.6
ENST00000397852.1 |
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
chr11_-_73687997 | 24.92 |
ENST00000545212.1
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier) |
chr14_-_94856951 | 24.91 |
ENST00000553327.1
ENST00000556955.1 ENST00000557118.1 ENST00000440909.1 |
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
chr1_-_111743285 | 24.59 |
ENST00000357640.4
|
DENND2D
|
DENN/MADD domain containing 2D |
chr13_+_42031679 | 24.28 |
ENST00000379359.3
|
RGCC
|
regulator of cell cycle |
chr6_+_29691198 | 24.14 |
ENST00000440587.2
ENST00000434407.2 |
HLA-F
|
major histocompatibility complex, class I, F |
chr17_+_78075361 | 23.95 |
ENST00000577106.1
ENST00000390015.3 |
GAA
|
glucosidase, alpha; acid |
chr19_+_18284477 | 23.73 |
ENST00000407280.3
|
IFI30
|
interferon, gamma-inducible protein 30 |
chr2_-_89157161 | 23.63 |
ENST00000390237.2
|
IGKC
|
immunoglobulin kappa constant |
chr2_-_89513402 | 23.30 |
ENST00000498435.1
|
IGKV1-27
|
immunoglobulin kappa variable 1-27 |
chr12_+_112204691 | 23.17 |
ENST00000416293.3
ENST00000261733.2 |
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial) |
chr22_+_23134974 | 22.91 |
ENST00000390314.2
|
IGLV2-11
|
immunoglobulin lambda variable 2-11 |
chr19_+_859425 | 22.58 |
ENST00000327726.6
|
CFD
|
complement factor D (adipsin) |
chr3_+_45071622 | 21.84 |
ENST00000428034.1
|
CLEC3B
|
C-type lectin domain family 3, member B |
chr16_-_88717423 | 21.66 |
ENST00000568278.1
ENST00000569359.1 ENST00000567174.1 |
CYBA
|
cytochrome b-245, alpha polypeptide |
chr19_+_1067492 | 21.56 |
ENST00000586866.1
|
HMHA1
|
histocompatibility (minor) HA-1 |
chr14_-_24911971 | 21.56 |
ENST00000555365.1
ENST00000399395.3 |
SDR39U1
|
short chain dehydrogenase/reductase family 39U, member 1 |
chr3_+_45067659 | 21.42 |
ENST00000296130.4
|
CLEC3B
|
C-type lectin domain family 3, member B |
chr6_+_31916733 | 20.95 |
ENST00000483004.1
|
CFB
|
complement factor B |
chr14_-_106111127 | 20.71 |
ENST00000390545.2
|
IGHG2
|
immunoglobulin heavy constant gamma 2 (G2m marker) |
chr6_+_31554962 | 20.14 |
ENST00000376092.3
ENST00000376086.3 ENST00000303757.8 ENST00000376093.2 ENST00000376102.3 |
LST1
|
leukocyte specific transcript 1 |
chr2_-_89266286 | 20.04 |
ENST00000464162.1
|
IGKV1-6
|
immunoglobulin kappa variable 1-6 |
chr5_-_149792295 | 19.64 |
ENST00000518797.1
ENST00000524315.1 ENST00000009530.7 ENST00000377795.3 |
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain |
chr1_+_22962948 | 19.54 |
ENST00000374642.3
|
C1QA
|
complement component 1, q subcomponent, A chain |
chr6_+_31555045 | 19.50 |
ENST00000396101.3
ENST00000490742.1 |
LST1
|
leukocyte specific transcript 1 |
chr6_+_33172407 | 19.50 |
ENST00000374662.3
|
HSD17B8
|
hydroxysteroid (17-beta) dehydrogenase 8 |
chrX_+_46940254 | 19.35 |
ENST00000336169.3
|
RGN
|
regucalcin |
chr11_+_313503 | 19.33 |
ENST00000528780.1
ENST00000328221.5 |
IFITM1
|
interferon induced transmembrane protein 1 |
chr11_-_73689037 | 19.15 |
ENST00000544615.1
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier) |
chr2_-_89278535 | 18.37 |
ENST00000390247.2
|
IGKV3-7
|
immunoglobulin kappa variable 3-7 (non-functional) |
chr1_+_119957554 | 18.30 |
ENST00000543831.1
ENST00000433745.1 ENST00000369416.3 |
HSD3B2
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 |
chr2_-_89442621 | 18.28 |
ENST00000492167.1
|
IGKV3-20
|
immunoglobulin kappa variable 3-20 |
chr1_-_229569834 | 18.19 |
ENST00000366684.3
ENST00000366683.2 |
ACTA1
|
actin, alpha 1, skeletal muscle |
chr14_-_24911448 | 18.18 |
ENST00000555355.1
ENST00000553343.1 ENST00000556523.1 ENST00000556249.1 ENST00000538105.2 ENST00000555225.1 |
SDR39U1
|
short chain dehydrogenase/reductase family 39U, member 1 |
chr1_-_173886491 | 18.12 |
ENST00000367698.3
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1 |
chr16_+_226658 | 17.91 |
ENST00000320868.5
ENST00000397797.1 |
HBA1
|
hemoglobin, alpha 1 |
chr9_-_116840728 | 17.85 |
ENST00000265132.3
|
AMBP
|
alpha-1-microglobulin/bikunin precursor |
chr7_+_150498783 | 17.80 |
ENST00000475536.1
ENST00000468689.1 |
TMEM176A
|
transmembrane protein 176A |
chr11_-_118213331 | 17.73 |
ENST00000392884.2
|
CD3D
|
CD3d molecule, delta (CD3-TCR complex) |
chr11_-_116968987 | 17.69 |
ENST00000434315.2
ENST00000292055.4 ENST00000375288.1 ENST00000542607.1 ENST00000445177.1 ENST00000375300.1 ENST00000446921.2 |
SIK3
|
SIK family kinase 3 |
chr2_-_136875712 | 17.63 |
ENST00000241393.3
|
CXCR4
|
chemokine (C-X-C motif) receptor 4 |
chr16_-_88717482 | 17.57 |
ENST00000261623.3
|
CYBA
|
cytochrome b-245, alpha polypeptide |
chr16_+_30194916 | 17.45 |
ENST00000570045.1
ENST00000565497.1 ENST00000570244.1 |
CORO1A
|
coronin, actin binding protein, 1A |
chr1_-_31230650 | 17.32 |
ENST00000294507.3
|
LAPTM5
|
lysosomal protein transmembrane 5 |
chr3_-_50340996 | 17.30 |
ENST00000266031.4
ENST00000395143.2 ENST00000457214.2 ENST00000447605.2 ENST00000418723.1 ENST00000395144.2 |
HYAL1
|
hyaluronoglucosaminidase 1 |
chr11_-_64512273 | 17.25 |
ENST00000377497.3
ENST00000377487.1 ENST00000430645.1 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
chr2_-_89292422 | 17.05 |
ENST00000495489.1
|
IGKV1-8
|
immunoglobulin kappa variable 1-8 |
chr16_+_85942594 | 17.01 |
ENST00000566369.1
|
IRF8
|
interferon regulatory factor 8 |
chr6_-_32557610 | 17.00 |
ENST00000360004.5
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1 |
chr14_+_92980111 | 16.93 |
ENST00000216487.7
ENST00000557762.1 |
RIN3
|
Ras and Rab interactor 3 |
chr17_-_76123101 | 16.91 |
ENST00000392467.3
|
TMC6
|
transmembrane channel-like 6 |
chr6_+_32709119 | 16.87 |
ENST00000374940.3
|
HLA-DQA2
|
major histocompatibility complex, class II, DQ alpha 2 |
chr11_+_57365150 | 16.81 |
ENST00000457869.1
ENST00000340687.6 ENST00000378323.4 ENST00000378324.2 ENST00000403558.1 |
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 |
chr3_+_14989186 | 16.80 |
ENST00000435454.1
ENST00000323373.6 |
NR2C2
|
nuclear receptor subfamily 2, group C, member 2 |
chr8_+_142402089 | 16.75 |
ENST00000521578.1
ENST00000520105.1 ENST00000523147.1 |
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3 |
chr19_+_859654 | 16.47 |
ENST00000592860.1
|
CFD
|
complement factor D (adipsin) |
chr12_-_117537240 | 16.47 |
ENST00000392545.4
ENST00000541210.1 ENST00000335209.7 |
TESC
|
tescalcin |
chr14_+_24630465 | 16.45 |
ENST00000557894.1
ENST00000559284.1 ENST00000560275.1 |
IRF9
|
interferon regulatory factor 9 |
chrX_-_106960285 | 16.45 |
ENST00000503515.1
ENST00000372397.2 |
TSC22D3
|
TSC22 domain family, member 3 |
chr19_-_10450287 | 16.42 |
ENST00000589261.1
ENST00000590569.1 ENST00000589580.1 ENST00000589249.1 |
ICAM3
|
intercellular adhesion molecule 3 |
chr1_-_151345159 | 16.32 |
ENST00000458566.1
ENST00000447402.3 ENST00000426705.2 ENST00000435071.1 ENST00000368868.5 |
SELENBP1
|
selenium binding protein 1 |
chr19_+_35773242 | 16.21 |
ENST00000222304.3
|
HAMP
|
hepcidin antimicrobial peptide |
chr22_-_51021397 | 16.10 |
ENST00000406938.2
|
CHKB
|
choline kinase beta |
chr1_+_152635854 | 16.09 |
ENST00000368784.1
|
LCE2D
|
late cornified envelope 2D |
chr2_+_219264466 | 16.07 |
ENST00000273062.2
|
CTDSP1
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 1 |
chr11_-_5271122 | 15.94 |
ENST00000330597.3
|
HBG1
|
hemoglobin, gamma A |
chr4_-_2264015 | 15.92 |
ENST00000337190.2
|
MXD4
|
MAX dimerization protein 4 |
chr1_+_28199047 | 15.81 |
ENST00000373925.1
ENST00000328928.7 ENST00000373927.3 ENST00000427466.1 ENST00000442118.1 ENST00000373921.3 |
THEMIS2
|
thymocyte selection associated family member 2 |
chr7_-_150038704 | 15.81 |
ENST00000466675.1
ENST00000482669.1 ENST00000467793.1 ENST00000223271.3 |
RARRES2
|
retinoic acid receptor responder (tazarotene induced) 2 |
chr19_+_10197463 | 15.78 |
ENST00000590378.1
ENST00000397881.3 |
C19orf66
|
chromosome 19 open reading frame 66 |
chr17_+_4854375 | 15.74 |
ENST00000521811.1
ENST00000519602.1 ENST00000323997.6 ENST00000522249.1 ENST00000519584.1 |
ENO3
|
enolase 3 (beta, muscle) |
chr14_-_106406090 | 15.72 |
ENST00000390593.2
|
IGHV6-1
|
immunoglobulin heavy variable 6-1 |
chr19_-_13213662 | 15.54 |
ENST00000264824.4
|
LYL1
|
lymphoblastic leukemia derived sequence 1 |
chr7_-_95025661 | 15.50 |
ENST00000542556.1
ENST00000265627.5 ENST00000427422.1 ENST00000451904.1 |
PON1
PON3
|
paraoxonase 1 paraoxonase 3 |
chr19_-_39108568 | 15.50 |
ENST00000586296.1
|
MAP4K1
|
mitogen-activated protein kinase kinase kinase kinase 1 |
chr22_-_17702729 | 15.40 |
ENST00000449907.2
ENST00000441548.1 ENST00000399839.1 |
CECR1
|
cat eye syndrome chromosome region, candidate 1 |
chr11_-_64511575 | 15.39 |
ENST00000431822.1
ENST00000377486.3 ENST00000394432.3 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
chr17_+_78075498 | 15.36 |
ENST00000302262.3
|
GAA
|
glucosidase, alpha; acid |
chr11_-_407103 | 15.35 |
ENST00000526395.1
|
SIGIRR
|
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain |
chr4_-_71532339 | 15.27 |
ENST00000254801.4
|
IGJ
|
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides |
chr17_-_34207295 | 15.26 |
ENST00000463941.1
ENST00000293272.3 |
CCL5
|
chemokine (C-C motif) ligand 5 |
chr19_-_19754404 | 15.15 |
ENST00000587205.1
ENST00000445806.2 ENST00000203556.4 |
GMIP
|
GEM interacting protein |
chr22_-_36013368 | 15.15 |
ENST00000442617.1
ENST00000397326.2 ENST00000397328.1 ENST00000451685.1 |
MB
|
myoglobin |
chr6_-_32636145 | 15.12 |
ENST00000399084.1
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1 |
chr14_+_23016437 | 15.05 |
ENST00000478163.3
|
TRAC
|
T cell receptor alpha constant |
chr9_-_137809718 | 15.05 |
ENST00000371806.3
|
FCN1
|
ficolin (collagen/fibrinogen domain containing) 1 |
chr12_+_121163538 | 15.03 |
ENST00000242592.4
|
ACADS
|
acyl-CoA dehydrogenase, C-2 to C-3 short chain |
chr2_-_89619904 | 14.92 |
ENST00000498574.1
|
IGKV1-39
|
immunoglobulin kappa variable 1-39 (gene/pseudogene) |
chr16_+_30710462 | 14.83 |
ENST00000262518.4
ENST00000395059.2 ENST00000344771.4 |
SRCAP
|
Snf2-related CREBBP activator protein |
chr14_-_106330458 | 14.81 |
ENST00000461719.1
|
IGHJ4
|
immunoglobulin heavy joining 4 |
chr15_-_45670924 | 14.62 |
ENST00000396659.3
|
GATM
|
glycine amidinotransferase (L-arginine:glycine amidinotransferase) |
chr3_-_52486841 | 14.61 |
ENST00000496590.1
|
TNNC1
|
troponin C type 1 (slow) |
chr19_+_45409011 | 14.59 |
ENST00000252486.4
ENST00000446996.1 ENST00000434152.1 |
APOE
|
apolipoprotein E |
chr6_+_31554779 | 14.56 |
ENST00000376090.2
|
LST1
|
leukocyte specific transcript 1 |
chr19_-_6690723 | 14.52 |
ENST00000601008.1
|
C3
|
complement component 3 |
chr1_+_209929494 | 14.50 |
ENST00000367026.3
|
TRAF3IP3
|
TRAF3 interacting protein 3 |
chr22_+_22936998 | 14.40 |
ENST00000390303.2
|
IGLV3-32
|
immunoglobulin lambda variable 3-32 (non-functional) |
chr22_+_22712087 | 14.40 |
ENST00000390294.2
|
IGLV1-47
|
immunoglobulin lambda variable 1-47 |
chr22_+_23089870 | 14.28 |
ENST00000390311.2
|
IGLV3-16
|
immunoglobulin lambda variable 3-16 |
chr12_-_122296755 | 14.28 |
ENST00000289004.4
|
HPD
|
4-hydroxyphenylpyruvate dioxygenase |
chr19_+_1205740 | 14.25 |
ENST00000326873.7
|
STK11
|
serine/threonine kinase 11 |
chr12_-_15104040 | 14.21 |
ENST00000541644.1
ENST00000545895.1 |
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta |
chrX_+_44732757 | 14.08 |
ENST00000377967.4
ENST00000536777.1 ENST00000382899.4 ENST00000543216.1 |
KDM6A
|
lysine (K)-specific demethylase 6A |
chr17_-_2614927 | 14.06 |
ENST00000435359.1
|
CLUH
|
clustered mitochondria (cluA/CLU1) homolog |
chr16_-_28937027 | 14.02 |
ENST00000358201.4
|
RABEP2
|
rabaptin, RAB GTPase binding effector protein 2 |
chr9_+_140513438 | 13.98 |
ENST00000462484.1
ENST00000334856.6 ENST00000460843.1 |
EHMT1
|
euchromatic histone-lysine N-methyltransferase 1 |
chr2_+_90139056 | 13.90 |
ENST00000492446.1
|
IGKV1D-16
|
immunoglobulin kappa variable 1D-16 |
chr22_+_47158518 | 13.84 |
ENST00000337137.4
ENST00000380995.1 ENST00000407381.3 |
TBC1D22A
|
TBC1 domain family, member 22A |
chr19_-_10446449 | 13.84 |
ENST00000592439.1
|
ICAM3
|
intercellular adhesion molecule 3 |
chr14_+_105952648 | 13.72 |
ENST00000330233.7
|
CRIP1
|
cysteine-rich protein 1 (intestinal) |
chr7_+_142960505 | 13.71 |
ENST00000409500.3
ENST00000443571.2 ENST00000358406.5 ENST00000479303.1 |
GSTK1
|
glutathione S-transferase kappa 1 |
chr14_-_21492113 | 13.65 |
ENST00000554094.1
|
NDRG2
|
NDRG family member 2 |
chrX_-_70331298 | 13.64 |
ENST00000456850.2
ENST00000473378.1 ENST00000487883.1 ENST00000374202.2 |
IL2RG
|
interleukin 2 receptor, gamma |
chr2_+_90248739 | 13.60 |
ENST00000468879.1
|
IGKV1D-43
|
immunoglobulin kappa variable 1D-43 |
chr7_+_150264365 | 13.52 |
ENST00000255945.2
ENST00000461940.1 |
GIMAP4
|
GTPase, IMAP family member 4 |
chr19_+_42301079 | 13.49 |
ENST00000596544.1
|
CEACAM3
|
carcinoembryonic antigen-related cell adhesion molecule 3 |
chr22_+_23101182 | 13.47 |
ENST00000390312.2
|
IGLV2-14
|
immunoglobulin lambda variable 2-14 |
chr14_+_105953246 | 13.43 |
ENST00000392531.3
|
CRIP1
|
cysteine-rich protein 1 (intestinal) |
chr8_-_6837602 | 13.41 |
ENST00000382692.2
|
DEFA1
|
defensin, alpha 1 |
chr15_-_78423763 | 13.39 |
ENST00000557846.1
|
CIB2
|
calcium and integrin binding family member 2 |
chr14_-_107095662 | 13.38 |
ENST00000390630.2
|
IGHV4-61
|
immunoglobulin heavy variable 4-61 |
chr22_+_37257015 | 13.37 |
ENST00000447071.1
ENST00000248899.6 ENST00000397147.4 |
NCF4
|
neutrophil cytosolic factor 4, 40kDa |
chr6_+_89790459 | 13.34 |
ENST00000369472.1
|
PNRC1
|
proline-rich nuclear receptor coactivator 1 |
chr14_-_101295407 | 13.27 |
ENST00000596284.1
|
AL117190.2
|
AL117190.2 |
chr2_+_90077680 | 13.23 |
ENST00000390270.2
|
IGKV3D-20
|
immunoglobulin kappa variable 3D-20 |
chr19_-_51568324 | 13.18 |
ENST00000595547.1
ENST00000335422.3 ENST00000595793.1 ENST00000596955.1 |
KLK13
|
kallikrein-related peptidase 13 |
chr15_-_22473353 | 13.17 |
ENST00000557788.2
|
IGHV4OR15-8
|
immunoglobulin heavy variable 4/OR15-8 (non-functional) |
chr1_-_104239076 | 13.11 |
ENST00000370080.3
|
AMY1B
|
amylase, alpha 1B (salivary) |
chr6_+_6588316 | 13.11 |
ENST00000379953.2
|
LY86
|
lymphocyte antigen 86 |
chr4_-_926069 | 13.10 |
ENST00000314167.4
ENST00000502656.1 |
GAK
|
cyclin G associated kinase |
chr6_+_89790490 | 13.07 |
ENST00000336032.3
|
PNRC1
|
proline-rich nuclear receptor coactivator 1 |
chr6_-_31324943 | 13.07 |
ENST00000412585.2
ENST00000434333.1 |
HLA-B
|
major histocompatibility complex, class I, B |
chr19_+_2389784 | 12.97 |
ENST00000332578.3
|
TMPRSS9
|
transmembrane protease, serine 9 |
chr14_-_106733624 | 12.97 |
ENST00000390610.2
|
IGHV1-24
|
immunoglobulin heavy variable 1-24 |
chr2_-_89385283 | 12.89 |
ENST00000390252.2
|
IGKV3-15
|
immunoglobulin kappa variable 3-15 |
chr6_+_33048222 | 12.88 |
ENST00000428835.1
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1 |
chr6_+_32605134 | 12.86 |
ENST00000343139.5
ENST00000395363.1 ENST00000496318.1 |
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1 |
chr18_+_29171689 | 12.85 |
ENST00000237014.3
|
TTR
|
transthyretin |
chr2_+_90153696 | 12.85 |
ENST00000417279.2
|
IGKV3D-15
|
immunoglobulin kappa variable 3D-15 (gene/pseudogene) |
chr19_-_54872556 | 12.85 |
ENST00000444687.1
|
LAIR1
|
leukocyte-associated immunoglobulin-like receptor 1 |
chr7_+_150498610 | 12.81 |
ENST00000461345.1
|
TMEM176A
|
transmembrane protein 176A |
chr1_-_24194771 | 12.80 |
ENST00000374479.3
|
FUCA1
|
fucosidase, alpha-L- 1, tissue |
chr14_-_107283278 | 12.74 |
ENST00000390639.2
|
IGHV7-81
|
immunoglobulin heavy variable 7-81 (non-functional) |
chr19_-_55668093 | 12.70 |
ENST00000588882.1
ENST00000586858.1 |
TNNI3
|
troponin I type 3 (cardiac) |
chr2_+_220492116 | 12.65 |
ENST00000373760.2
|
SLC4A3
|
solute carrier family 4 (anion exchanger), member 3 |
chr9_+_74526384 | 12.59 |
ENST00000334731.2
ENST00000377031.3 |
C9orf85
|
chromosome 9 open reading frame 85 |
chr19_+_5623186 | 12.57 |
ENST00000538656.1
|
SAFB
|
scaffold attachment factor B |
chr1_+_38022513 | 12.52 |
ENST00000296218.7
|
DNALI1
|
dynein, axonemal, light intermediate chain 1 |
chr14_-_24780573 | 12.51 |
ENST00000336557.5
ENST00000258807.5 |
CIDEB
|
cell death-inducing DFFA-like effector b |
chr1_+_22963158 | 12.50 |
ENST00000438241.1
|
C1QA
|
complement component 1, q subcomponent, A chain |
chr17_-_62097904 | 12.49 |
ENST00000583366.1
|
ICAM2
|
intercellular adhesion molecule 2 |
chr22_-_39636914 | 12.48 |
ENST00000381551.4
|
PDGFB
|
platelet-derived growth factor beta polypeptide |
chr5_-_149492904 | 12.45 |
ENST00000286301.3
ENST00000511344.1 |
CSF1R
|
colony stimulating factor 1 receptor |
chr11_+_65405556 | 12.42 |
ENST00000534313.1
ENST00000533361.1 ENST00000526137.1 |
SIPA1
|
signal-induced proliferation-associated 1 |
chr19_-_10450328 | 12.38 |
ENST00000160262.5
|
ICAM3
|
intercellular adhesion molecule 3 |
chr22_+_22676808 | 12.35 |
ENST00000390290.2
|
IGLV1-51
|
immunoglobulin lambda variable 1-51 |
chr2_+_105471969 | 12.30 |
ENST00000361360.2
|
POU3F3
|
POU class 3 homeobox 3 |
chr19_-_10445399 | 12.28 |
ENST00000592945.1
|
ICAM3
|
intercellular adhesion molecule 3 |
chr3_-_52860850 | 12.26 |
ENST00000441637.2
|
ITIH4
|
inter-alpha-trypsin inhibitor heavy chain family, member 4 |
chr22_+_20104947 | 12.23 |
ENST00000402752.1
|
RANBP1
|
RAN binding protein 1 |
chr16_+_33605231 | 12.15 |
ENST00000570121.2
|
IGHV3OR16-12
|
immunoglobulin heavy variable 3/OR16-12 (non-functional) |
chr19_+_58694396 | 12.14 |
ENST00000326804.4
ENST00000345813.3 ENST00000424679.2 |
ZNF274
|
zinc finger protein 274 |
chr14_+_61654271 | 11.97 |
ENST00000555185.1
ENST00000557294.1 ENST00000556778.1 |
PRKCH
|
protein kinase C, eta |
chr8_-_6875778 | 11.96 |
ENST00000535841.1
ENST00000327857.2 |
DEFA1B
DEFA3
|
defensin, alpha 1B defensin, alpha 3, neutrophil-specific |
chr5_-_131347501 | 11.93 |
ENST00000543479.1
|
ACSL6
|
acyl-CoA synthetase long-chain family member 6 |
chr6_+_31554826 | 11.89 |
ENST00000376089.2
ENST00000396112.2 |
LST1
|
leukocyte specific transcript 1 |
chr14_-_21492251 | 11.89 |
ENST00000554398.1
|
NDRG2
|
NDRG family member 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
24.0 | 240.4 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
15.5 | 46.4 | GO:1902994 | regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
14.3 | 57.0 | GO:0002086 | diaphragm contraction(GO:0002086) |
12.0 | 36.1 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
10.7 | 739.9 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
10.5 | 10.5 | GO:2001190 | positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001190) |
10.0 | 40.0 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
9.7 | 29.1 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
9.2 | 27.7 | GO:1903413 | cellular response to bile acid(GO:1903413) |
8.4 | 25.1 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
8.1 | 24.4 | GO:0033212 | iron assimilation(GO:0033212) iron assimilation by chelation and transport(GO:0033214) positive regulation of bone mineralization involved in bone maturation(GO:1900159) negative regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000308) |
8.1 | 8.1 | GO:0051784 | negative regulation of nuclear division(GO:0051784) |
7.9 | 7.9 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
7.8 | 39.2 | GO:1904844 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
7.7 | 38.6 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
7.7 | 23.1 | GO:0002894 | positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
7.5 | 74.9 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
7.3 | 29.2 | GO:0071461 | cellular response to redox state(GO:0071461) |
7.2 | 21.5 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
7.1 | 92.2 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
7.0 | 21.1 | GO:0051673 | pore formation in membrane of other organism(GO:0035915) membrane disruption in other organism(GO:0051673) |
7.0 | 34.8 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
6.8 | 88.6 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
6.5 | 32.7 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
6.5 | 25.9 | GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling(GO:0010903) |
6.3 | 25.4 | GO:1905174 | metanephric glomerular mesangial cell development(GO:0072255) reversible differentiation(GO:0090677) cell dedifferentiation involved in phenotypic switching(GO:0090678) positive regulation of phenotypic switching(GO:1900241) regulation of vascular smooth muscle cell dedifferentiation(GO:1905174) positive regulation of vascular smooth muscle cell dedifferentiation(GO:1905176) vascular smooth muscle cell dedifferentiation(GO:1990936) |
6.3 | 18.8 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
6.2 | 18.7 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
6.1 | 18.3 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) |
6.1 | 12.1 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
5.8 | 17.5 | GO:1900075 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
5.8 | 46.2 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
5.7 | 28.7 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
5.7 | 5.7 | GO:0002731 | negative regulation of dendritic cell cytokine production(GO:0002731) |
5.7 | 28.6 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
5.7 | 17.0 | GO:0061760 | antifungal innate immune response(GO:0061760) |
5.6 | 27.9 | GO:0002399 | MHC class II protein complex assembly(GO:0002399) |
5.2 | 26.0 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
5.2 | 5.2 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
5.1 | 30.6 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
5.1 | 15.2 | GO:0038124 | toll-like receptor TLR6:TLR2 signaling pathway(GO:0038124) response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
5.0 | 20.0 | GO:0042335 | cuticle development(GO:0042335) |
5.0 | 14.9 | GO:0002818 | intracellular defense response(GO:0002818) |
4.9 | 24.5 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
4.9 | 29.4 | GO:0090131 | mesenchyme migration(GO:0090131) |
4.8 | 19.3 | GO:0090346 | cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
4.8 | 33.4 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
4.7 | 18.9 | GO:0035995 | detection of muscle stretch(GO:0035995) |
4.7 | 23.6 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
4.7 | 14.1 | GO:0019556 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
4.7 | 14.1 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
4.7 | 14.1 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
4.7 | 18.6 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
4.6 | 18.6 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
4.6 | 13.7 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
4.6 | 68.4 | GO:0015671 | oxygen transport(GO:0015671) |
4.6 | 36.5 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
4.5 | 4.5 | GO:0006789 | bilirubin conjugation(GO:0006789) |
4.5 | 13.6 | GO:1904298 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
4.5 | 13.5 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
4.4 | 390.2 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
4.4 | 13.3 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
4.4 | 4.4 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
4.4 | 17.4 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
4.3 | 99.7 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
4.3 | 13.0 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
4.2 | 12.6 | GO:1903027 | regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
4.2 | 4.2 | GO:0042560 | folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
4.1 | 12.4 | GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) |
4.1 | 20.7 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
4.1 | 4.1 | GO:0042701 | progesterone secretion(GO:0042701) |
4.0 | 4.0 | GO:0046321 | positive regulation of fatty acid oxidation(GO:0046321) |
4.0 | 11.9 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
4.0 | 27.8 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
3.9 | 15.8 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
3.9 | 15.8 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
3.9 | 19.4 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
3.8 | 11.5 | GO:0071321 | cellular response to cGMP(GO:0071321) |
3.8 | 26.6 | GO:0006562 | proline catabolic process(GO:0006562) |
3.8 | 11.4 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
3.8 | 22.6 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
3.8 | 11.3 | GO:0019732 | antifungal humoral response(GO:0019732) |
3.8 | 22.5 | GO:0010734 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
3.7 | 18.7 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
3.7 | 22.3 | GO:0070560 | protein secretion by platelet(GO:0070560) |
3.7 | 11.1 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
3.7 | 7.4 | GO:0006705 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
3.7 | 69.7 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
3.7 | 14.7 | GO:0042361 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
3.7 | 18.3 | GO:0015670 | carbon dioxide transport(GO:0015670) |
3.6 | 10.9 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
3.6 | 25.4 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
3.6 | 21.6 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
3.6 | 14.4 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
3.6 | 10.8 | GO:0097254 | renal tubular secretion(GO:0097254) |
3.6 | 17.8 | GO:0001878 | response to yeast(GO:0001878) |
3.5 | 3.5 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
3.5 | 10.5 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
3.5 | 14.0 | GO:0060992 | response to fungicide(GO:0060992) |
3.5 | 7.0 | GO:0052199 | negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) |
3.5 | 24.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
3.4 | 3.4 | GO:0001927 | exocyst assembly(GO:0001927) |
3.4 | 10.2 | GO:1902530 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
3.4 | 10.2 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
3.4 | 54.4 | GO:0071318 | cellular response to ATP(GO:0071318) |
3.4 | 23.6 | GO:0046618 | drug export(GO:0046618) |
3.3 | 3.3 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
3.3 | 26.6 | GO:0070236 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
3.3 | 9.9 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
3.3 | 16.4 | GO:0098707 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
3.3 | 3.3 | GO:0016071 | mRNA metabolic process(GO:0016071) |
3.3 | 13.0 | GO:0005985 | sucrose metabolic process(GO:0005985) |
3.3 | 16.3 | GO:1905225 | response to thyrotropin-releasing hormone(GO:1905225) |
3.2 | 16.2 | GO:1903906 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
3.2 | 19.4 | GO:0034587 | piRNA metabolic process(GO:0034587) |
3.2 | 3.2 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
3.2 | 9.7 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
3.2 | 16.1 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
3.2 | 12.9 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
3.2 | 16.0 | GO:0072233 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
3.2 | 57.0 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
3.1 | 22.0 | GO:0032025 | response to cobalt ion(GO:0032025) |
3.1 | 9.4 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
3.1 | 31.2 | GO:0001955 | blood vessel maturation(GO:0001955) |
3.1 | 24.8 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
3.1 | 9.3 | GO:1901899 | positive regulation of relaxation of cardiac muscle(GO:1901899) |
3.1 | 21.7 | GO:0002933 | lipid hydroxylation(GO:0002933) |
3.1 | 9.3 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
3.1 | 9.2 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
3.0 | 3.0 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
3.0 | 12.1 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
3.0 | 9.1 | GO:1904397 | negative regulation of neuromuscular junction development(GO:1904397) |
3.0 | 15.1 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) |
3.0 | 30.0 | GO:0006069 | ethanol oxidation(GO:0006069) |
3.0 | 8.9 | GO:0003095 | pressure natriuresis(GO:0003095) |
3.0 | 3.0 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
3.0 | 11.8 | GO:2000314 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
3.0 | 3.0 | GO:0035106 | operant conditioning(GO:0035106) |
2.9 | 8.8 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
2.9 | 14.6 | GO:1902572 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
2.9 | 2.9 | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
2.9 | 14.5 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
2.9 | 17.3 | GO:0006196 | AMP catabolic process(GO:0006196) |
2.9 | 2.9 | GO:0045073 | regulation of chemokine biosynthetic process(GO:0045073) |
2.9 | 5.7 | GO:0001812 | regulation of type I hypersensitivity(GO:0001810) positive regulation of type I hypersensitivity(GO:0001812) type I hypersensitivity(GO:0016068) |
2.8 | 8.5 | GO:0015729 | thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
2.8 | 42.7 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
2.8 | 31.2 | GO:0006600 | creatine metabolic process(GO:0006600) |
2.8 | 11.3 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
2.8 | 8.5 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
2.8 | 16.8 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
2.8 | 11.2 | GO:0061107 | seminal vesicle development(GO:0061107) |
2.8 | 11.1 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
2.8 | 8.3 | GO:0046730 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
2.8 | 8.3 | GO:0043605 | cellular amide catabolic process(GO:0043605) |
2.8 | 5.5 | GO:0072348 | sulfur compound transport(GO:0072348) |
2.8 | 8.3 | GO:2000397 | ubiquitin-dependent endocytosis(GO:0070086) regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
2.7 | 16.5 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
2.7 | 13.7 | GO:0048539 | bone marrow development(GO:0048539) |
2.7 | 8.2 | GO:0003285 | septum secundum development(GO:0003285) |
2.7 | 2.7 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
2.7 | 8.2 | GO:1904640 | response to methionine(GO:1904640) |
2.7 | 16.1 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
2.7 | 5.3 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
2.7 | 2.7 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
2.6 | 5.3 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
2.6 | 5.2 | GO:0070295 | renal water absorption(GO:0070295) |
2.6 | 7.8 | GO:2000547 | dendritic cell dendrite assembly(GO:0097026) regulation of dendritic cell dendrite assembly(GO:2000547) |
2.6 | 18.2 | GO:0051006 | positive regulation of lipoprotein lipase activity(GO:0051006) |
2.6 | 13.0 | GO:0016045 | detection of bacterium(GO:0016045) |
2.6 | 5.2 | GO:0042246 | tissue regeneration(GO:0042246) |
2.6 | 2.6 | GO:0021539 | subthalamus development(GO:0021539) |
2.6 | 5.2 | GO:0036101 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
2.6 | 7.7 | GO:1902996 | regulation of neurofibrillary tangle assembly(GO:1902996) |
2.6 | 15.4 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
2.6 | 7.7 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
2.5 | 10.2 | GO:0018094 | protein polyglycylation(GO:0018094) |
2.5 | 15.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
2.5 | 20.2 | GO:0015705 | iodide transport(GO:0015705) |
2.5 | 15.1 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
2.5 | 2.5 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
2.5 | 17.5 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
2.5 | 7.4 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
2.5 | 2.5 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
2.5 | 4.9 | GO:0070541 | response to platinum ion(GO:0070541) |
2.5 | 9.9 | GO:0002347 | response to tumor cell(GO:0002347) |
2.4 | 7.3 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
2.4 | 17.1 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
2.4 | 7.3 | GO:2001303 | lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
2.4 | 24.3 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
2.4 | 4.9 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
2.4 | 7.2 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
2.4 | 9.6 | GO:0071231 | cellular response to folic acid(GO:0071231) |
2.4 | 2.4 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
2.4 | 2.4 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
2.4 | 47.8 | GO:0045730 | respiratory burst(GO:0045730) |
2.4 | 261.3 | GO:0031295 | T cell costimulation(GO:0031295) |
2.4 | 7.1 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
2.4 | 16.5 | GO:0044351 | macropinocytosis(GO:0044351) |
2.4 | 7.1 | GO:2001187 | positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
2.4 | 2.4 | GO:0051106 | positive regulation of DNA ligation(GO:0051106) |
2.3 | 28.2 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
2.3 | 34.9 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
2.3 | 7.0 | GO:0003166 | bundle of His development(GO:0003166) cardiac left ventricle formation(GO:0003218) |
2.3 | 6.9 | GO:0098759 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
2.3 | 9.2 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
2.3 | 2.3 | GO:0021558 | trochlear nerve development(GO:0021558) |
2.3 | 9.2 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
2.3 | 11.4 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
2.3 | 6.8 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
2.3 | 11.4 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
2.3 | 13.6 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
2.3 | 4.5 | GO:0002371 | dendritic cell cytokine production(GO:0002371) |
2.3 | 4.5 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
2.3 | 9.0 | GO:0046886 | positive regulation of hormone biosynthetic process(GO:0046886) |
2.2 | 6.7 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
2.2 | 4.5 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
2.2 | 13.3 | GO:0019532 | oxalate transport(GO:0019532) |
2.2 | 2.2 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
2.2 | 11.0 | GO:0048165 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
2.2 | 13.2 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
2.2 | 6.6 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
2.2 | 15.3 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
2.2 | 6.5 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
2.2 | 4.4 | GO:1902218 | regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
2.2 | 13.0 | GO:0010193 | response to ozone(GO:0010193) |
2.2 | 28.1 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
2.2 | 10.8 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
2.2 | 19.4 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) |
2.2 | 25.8 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
2.1 | 8.6 | GO:0071504 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
2.1 | 21.4 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
2.1 | 10.7 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
2.1 | 4.3 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
2.1 | 2.1 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
2.1 | 6.4 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
2.1 | 10.7 | GO:0009439 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
2.1 | 33.8 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
2.1 | 14.6 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
2.1 | 8.3 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
2.1 | 14.6 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
2.1 | 35.3 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
2.1 | 8.3 | GO:0070426 | positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
2.1 | 8.3 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
2.1 | 12.3 | GO:0071105 | response to interleukin-11(GO:0071105) |
2.0 | 8.2 | GO:0002442 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
2.0 | 6.1 | GO:0009447 | putrescine catabolic process(GO:0009447) |
2.0 | 2.0 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
2.0 | 2.0 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
2.0 | 14.2 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
2.0 | 14.2 | GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
2.0 | 8.0 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
2.0 | 24.1 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
2.0 | 12.0 | GO:0050666 | regulation of sulfur amino acid metabolic process(GO:0031335) regulation of homocysteine metabolic process(GO:0050666) |
2.0 | 8.0 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
2.0 | 6.0 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
2.0 | 6.0 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
2.0 | 29.9 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
2.0 | 4.0 | GO:0002249 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
2.0 | 2.0 | GO:0072672 | neutrophil extravasation(GO:0072672) regulation of neutrophil extravasation(GO:2000389) |
2.0 | 2.0 | GO:0043335 | protein unfolding(GO:0043335) |
2.0 | 3.9 | GO:1901216 | positive regulation of neuron death(GO:1901216) |
2.0 | 17.6 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
2.0 | 21.5 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
1.9 | 1.9 | GO:0046689 | response to mercury ion(GO:0046689) |
1.9 | 3.9 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
1.9 | 5.8 | GO:0018262 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
1.9 | 5.8 | GO:0060940 | epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
1.9 | 13.4 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
1.9 | 11.5 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
1.9 | 19.2 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
1.9 | 1.9 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
1.9 | 5.7 | GO:0035524 | proline transmembrane transport(GO:0035524) |
1.9 | 13.3 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
1.9 | 5.7 | GO:0060061 | Spemann organizer formation(GO:0060061) |
1.9 | 1.9 | GO:0051451 | myoblast migration(GO:0051451) |
1.9 | 5.7 | GO:0072139 | glomerular parietal epithelial cell differentiation(GO:0072139) |
1.9 | 7.5 | GO:0032763 | mast cell cytokine production(GO:0032762) regulation of mast cell cytokine production(GO:0032763) |
1.9 | 7.5 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
1.9 | 1.9 | GO:0048839 | inner ear development(GO:0048839) |
1.9 | 65.1 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
1.9 | 103.8 | GO:0006953 | acute-phase response(GO:0006953) |
1.8 | 1.8 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
1.8 | 3.7 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
1.8 | 7.4 | GO:1905071 | occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
1.8 | 3.7 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
1.8 | 240.6 | GO:0002377 | immunoglobulin production(GO:0002377) |
1.8 | 7.3 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
1.8 | 10.9 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
1.8 | 1.8 | GO:0044146 | negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
1.8 | 7.3 | GO:0046967 | cytosol to ER transport(GO:0046967) |
1.8 | 7.2 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
1.8 | 1.8 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
1.8 | 5.4 | GO:0048867 | stem cell fate determination(GO:0048867) |
1.8 | 5.4 | GO:0060023 | soft palate development(GO:0060023) |
1.8 | 3.6 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
1.8 | 5.3 | GO:0000354 | cis assembly of pre-catalytic spliceosome(GO:0000354) |
1.8 | 7.1 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
1.8 | 7.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
1.8 | 3.5 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
1.8 | 5.3 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
1.8 | 3.5 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) endodermal digestive tract morphogenesis(GO:0061031) |
1.8 | 7.0 | GO:0021784 | postganglionic parasympathetic fiber development(GO:0021784) |
1.8 | 8.8 | GO:0015811 | L-cystine transport(GO:0015811) |
1.7 | 3.5 | GO:0032660 | regulation of interleukin-17 production(GO:0032660) |
1.7 | 3.5 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
1.7 | 26.2 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
1.7 | 5.2 | GO:0002027 | regulation of heart rate(GO:0002027) |
1.7 | 3.5 | GO:0008050 | female courtship behavior(GO:0008050) |
1.7 | 1.7 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
1.7 | 17.2 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
1.7 | 6.7 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
1.7 | 5.0 | GO:0035900 | response to isolation stress(GO:0035900) |
1.7 | 10.0 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
1.7 | 5.0 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
1.7 | 13.4 | GO:0048102 | autophagic cell death(GO:0048102) |
1.7 | 5.0 | GO:2000538 | regulation of cGMP-mediated signaling(GO:0010752) regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
1.7 | 13.3 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
1.7 | 3.3 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
1.7 | 6.6 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
1.7 | 26.5 | GO:0006004 | fucose metabolic process(GO:0006004) |
1.6 | 24.7 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
1.6 | 8.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
1.6 | 3.3 | GO:0045940 | positive regulation of steroid metabolic process(GO:0045940) |
1.6 | 13.0 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
1.6 | 8.2 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
1.6 | 6.5 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
1.6 | 4.9 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
1.6 | 19.4 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
1.6 | 6.5 | GO:0044026 | DNA hypermethylation(GO:0044026) |
1.6 | 1.6 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
1.6 | 24.2 | GO:0036124 | histone H3-K9 trimethylation(GO:0036124) |
1.6 | 9.7 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
1.6 | 6.4 | GO:0043129 | surfactant homeostasis(GO:0043129) |
1.6 | 1.6 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
1.6 | 6.4 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
1.6 | 1.6 | GO:0030194 | positive regulation of blood coagulation(GO:0030194) positive regulation of coagulation(GO:0050820) positive regulation of hemostasis(GO:1900048) |
1.6 | 84.8 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
1.6 | 1.6 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
1.6 | 6.4 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
1.6 | 17.3 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
1.6 | 6.3 | GO:0008228 | opsonization(GO:0008228) |
1.6 | 3.1 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
1.6 | 1.6 | GO:0042420 | dopamine catabolic process(GO:0042420) |
1.6 | 4.7 | GO:0071025 | RNA surveillance(GO:0071025) |
1.5 | 17.0 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
1.5 | 7.7 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
1.5 | 3.1 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
1.5 | 10.8 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
1.5 | 16.9 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
1.5 | 4.6 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
1.5 | 1.5 | GO:0090164 | asymmetric Golgi ribbon formation(GO:0090164) |
1.5 | 6.0 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
1.5 | 9.0 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
1.5 | 10.5 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
1.5 | 6.0 | GO:1901162 | primary amino compound biosynthetic process(GO:1901162) |
1.5 | 1.5 | GO:1903626 | positive regulation of DNA catabolic process(GO:1903626) |
1.5 | 3.0 | GO:0014858 | positive regulation of skeletal muscle cell proliferation(GO:0014858) positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
1.5 | 1.5 | GO:0032620 | interleukin-17 production(GO:0032620) |
1.5 | 7.4 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
1.5 | 4.4 | GO:0046968 | peptide antigen transport(GO:0046968) |
1.5 | 10.3 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
1.5 | 10.2 | GO:0006116 | NADH oxidation(GO:0006116) |
1.5 | 4.4 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
1.5 | 4.4 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
1.5 | 7.3 | GO:0032431 | activation of phospholipase A2 activity(GO:0032431) |
1.5 | 17.4 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
1.4 | 4.3 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
1.4 | 2.9 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
1.4 | 4.3 | GO:0035565 | regulation of pronephros size(GO:0035565) renal glucose absorption(GO:0035623) |
1.4 | 8.7 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
1.4 | 17.3 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
1.4 | 4.3 | GO:0032571 | response to vitamin K(GO:0032571) |
1.4 | 1.4 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
1.4 | 83.3 | GO:0050672 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
1.4 | 2.9 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) |
1.4 | 4.3 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
1.4 | 1.4 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
1.4 | 4.3 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
1.4 | 2.8 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
1.4 | 4.2 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
1.4 | 4.2 | GO:0097688 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
1.4 | 2.8 | GO:0070781 | response to biotin(GO:0070781) |
1.4 | 9.8 | GO:0030432 | peristalsis(GO:0030432) |
1.4 | 2.8 | GO:0043307 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
1.4 | 23.6 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
1.4 | 4.2 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) |
1.4 | 4.2 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
1.4 | 4.1 | GO:0070431 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
1.4 | 4.1 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
1.4 | 5.5 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
1.4 | 1.4 | GO:1990637 | response to prolactin(GO:1990637) |
1.4 | 4.1 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
1.4 | 12.3 | GO:0060737 | prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
1.4 | 1.4 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
1.4 | 1.4 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
1.4 | 1.4 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
1.4 | 35.3 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
1.4 | 1.4 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
1.3 | 1.3 | GO:1904379 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
1.3 | 2.7 | GO:0038155 | positive regulation of T-helper 1 type immune response(GO:0002827) interleukin-23-mediated signaling pathway(GO:0038155) regulation of memory T cell differentiation(GO:0043380) positive regulation of memory T cell differentiation(GO:0043382) positive regulation of T-helper 17 cell lineage commitment(GO:2000330) |
1.3 | 4.0 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
1.3 | 24.0 | GO:0097186 | amelogenesis(GO:0097186) |
1.3 | 1.3 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
1.3 | 1.3 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
1.3 | 18.6 | GO:0070572 | positive regulation of neuron projection regeneration(GO:0070572) |
1.3 | 10.6 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
1.3 | 27.8 | GO:0033198 | response to ATP(GO:0033198) |
1.3 | 2.6 | GO:0070944 | neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
1.3 | 5.3 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
1.3 | 2.6 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
1.3 | 1.3 | GO:0099545 | trans-synaptic signaling by trans-synaptic complex(GO:0099545) |
1.3 | 2.6 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
1.3 | 3.9 | GO:0048820 | hair follicle maturation(GO:0048820) |
1.3 | 2.6 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
1.3 | 3.9 | GO:0044804 | nucleophagy(GO:0044804) |
1.3 | 12.9 | GO:0015886 | heme transport(GO:0015886) |
1.3 | 9.0 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
1.3 | 14.1 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
1.3 | 2.6 | GO:0008593 | regulation of Notch signaling pathway(GO:0008593) |
1.3 | 7.7 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
1.3 | 5.1 | GO:0009635 | response to herbicide(GO:0009635) |
1.3 | 3.8 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
1.3 | 26.5 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
1.3 | 31.5 | GO:0015695 | organic cation transport(GO:0015695) |
1.3 | 15.1 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
1.3 | 3.8 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
1.3 | 5.0 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
1.2 | 7.5 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
1.2 | 16.2 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
1.2 | 5.0 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
1.2 | 1.2 | GO:1903939 | regulation of TORC2 signaling(GO:1903939) |
1.2 | 1.2 | GO:0060926 | atrioventricular node development(GO:0003162) cardiac pacemaker cell differentiation(GO:0060920) cardiac pacemaker cell development(GO:0060926) |
1.2 | 5.0 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
1.2 | 7.4 | GO:0019530 | taurine metabolic process(GO:0019530) |
1.2 | 1.2 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
1.2 | 3.7 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
1.2 | 6.2 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
1.2 | 14.8 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
1.2 | 4.9 | GO:0014900 | muscle hyperplasia(GO:0014900) |
1.2 | 1.2 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
1.2 | 1.2 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
1.2 | 3.7 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
1.2 | 3.6 | GO:0060534 | trachea cartilage development(GO:0060534) |
1.2 | 10.9 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
1.2 | 1.2 | GO:0050856 | regulation of T cell receptor signaling pathway(GO:0050856) |
1.2 | 4.8 | GO:0003097 | renal water transport(GO:0003097) regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
1.2 | 19.2 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
1.2 | 2.4 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
1.2 | 6.0 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
1.2 | 17.9 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
1.2 | 3.6 | GO:0014887 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
1.2 | 2.4 | GO:1903598 | angiotensin-mediated drinking behavior(GO:0003051) positive regulation of gap junction assembly(GO:1903598) |
1.2 | 2.4 | GO:0071569 | protein ufmylation(GO:0071569) |
1.2 | 3.6 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
1.2 | 8.3 | GO:0086047 | membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
1.2 | 7.1 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
1.2 | 7.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
1.2 | 5.9 | GO:0044245 | polysaccharide digestion(GO:0044245) |
1.2 | 5.9 | GO:0035063 | nuclear speck organization(GO:0035063) |
1.2 | 3.5 | GO:0036343 | psychomotor behavior(GO:0036343) |
1.2 | 3.5 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
1.2 | 3.5 | GO:0090035 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
1.2 | 12.8 | GO:0006657 | CDP-choline pathway(GO:0006657) |
1.2 | 3.5 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
1.2 | 8.1 | GO:0036065 | fucosylation(GO:0036065) |
1.2 | 11.5 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
1.1 | 9.2 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
1.1 | 10.3 | GO:0097167 | circadian regulation of translation(GO:0097167) |
1.1 | 6.9 | GO:0042116 | macrophage activation(GO:0042116) |
1.1 | 10.3 | GO:0030220 | platelet formation(GO:0030220) |
1.1 | 6.9 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
1.1 | 1.1 | GO:0032965 | regulation of collagen biosynthetic process(GO:0032965) |
1.1 | 25.0 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
1.1 | 9.1 | GO:0070995 | NADPH oxidation(GO:0070995) |
1.1 | 3.4 | GO:1904482 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
1.1 | 6.8 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
1.1 | 5.7 | GO:0048664 | neuron fate determination(GO:0048664) |
1.1 | 3.4 | GO:0071918 | urea transmembrane transport(GO:0071918) |
1.1 | 5.6 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
1.1 | 4.5 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
1.1 | 3.4 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
1.1 | 5.6 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
1.1 | 4.5 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
1.1 | 12.4 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
1.1 | 9.0 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) |
1.1 | 4.5 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
1.1 | 1.1 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
1.1 | 2.2 | GO:1904970 | brush border assembly(GO:1904970) |
1.1 | 51.4 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
1.1 | 48.0 | GO:0015701 | bicarbonate transport(GO:0015701) |
1.1 | 2.2 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
1.1 | 12.3 | GO:0045008 | depyrimidination(GO:0045008) |
1.1 | 2.2 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
1.1 | 3.3 | GO:0051552 | flavone metabolic process(GO:0051552) |
1.1 | 1.1 | GO:0043379 | memory T cell differentiation(GO:0043379) |
1.1 | 9.9 | GO:0045023 | G0 to G1 transition(GO:0045023) |
1.1 | 5.5 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
1.1 | 1.1 | GO:0048638 | regulation of developmental growth(GO:0048638) |
1.1 | 10.9 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
1.1 | 3.3 | GO:0071529 | cementum mineralization(GO:0071529) |
1.1 | 4.4 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
1.1 | 2.2 | GO:1990418 | response to insulin-like growth factor stimulus(GO:1990418) |
1.1 | 5.4 | GO:1901094 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
1.1 | 7.6 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
1.1 | 1.1 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
1.1 | 1.1 | GO:0070673 | response to interleukin-18(GO:0070673) |
1.1 | 7.5 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
1.1 | 4.3 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
1.1 | 2.1 | GO:0001889 | liver development(GO:0001889) hepaticobiliary system development(GO:0061008) |
1.1 | 5.4 | GO:0032455 | nerve growth factor processing(GO:0032455) |
1.1 | 25.7 | GO:0042572 | retinol metabolic process(GO:0042572) |
1.1 | 2.1 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
1.1 | 3.2 | GO:0090208 | positive regulation of triglyceride metabolic process(GO:0090208) |
1.1 | 22.5 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
1.1 | 4.3 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) positive regulation of activation of Janus kinase activity(GO:0010536) |
1.1 | 12.8 | GO:0050798 | activated T cell proliferation(GO:0050798) |
1.1 | 3.2 | GO:0071301 | cellular response to vitamin B1(GO:0071301) response to formaldehyde(GO:1904404) |
1.1 | 2.1 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
1.1 | 2.1 | GO:0006711 | estrogen catabolic process(GO:0006711) |
1.1 | 3.2 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
1.1 | 2.1 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
1.1 | 11.6 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
1.1 | 1.1 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
1.1 | 5.3 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
1.1 | 16.8 | GO:0051639 | actin filament network formation(GO:0051639) |
1.0 | 1.0 | GO:2001267 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) |
1.0 | 4.2 | GO:0040016 | embryonic cleavage(GO:0040016) |
1.0 | 3.1 | GO:0090191 | negative regulation of mesonephros development(GO:0061218) negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
1.0 | 3.1 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
1.0 | 3.1 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
1.0 | 2.1 | GO:0042700 | luteinizing hormone signaling pathway(GO:0042700) |
1.0 | 2.1 | GO:0044793 | negative regulation by host of viral process(GO:0044793) |
1.0 | 2.1 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
1.0 | 2.1 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) positive regulation of guanylate cyclase activity(GO:0031284) |
1.0 | 2.0 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
1.0 | 6.1 | GO:0016926 | protein desumoylation(GO:0016926) |
1.0 | 3.0 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
1.0 | 3.0 | GO:0034227 | tRNA thio-modification(GO:0034227) |
1.0 | 5.0 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
1.0 | 4.0 | GO:0002118 | aggressive behavior(GO:0002118) |
1.0 | 4.0 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
1.0 | 1.0 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
1.0 | 2.0 | GO:0010818 | T cell chemotaxis(GO:0010818) |
1.0 | 6.0 | GO:2001023 | regulation of response to drug(GO:2001023) |
1.0 | 18.7 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
1.0 | 6.9 | GO:0048014 | Tie signaling pathway(GO:0048014) |
1.0 | 10.8 | GO:0051181 | cofactor transport(GO:0051181) |
1.0 | 2.0 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
1.0 | 2.0 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
1.0 | 8.8 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
1.0 | 180.5 | GO:0002250 | adaptive immune response(GO:0002250) |
1.0 | 3.9 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
1.0 | 16.5 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
1.0 | 6.8 | GO:0006772 | thiamine metabolic process(GO:0006772) |
1.0 | 6.8 | GO:0007000 | nucleolus organization(GO:0007000) |
1.0 | 2.9 | GO:0003014 | renal system process(GO:0003014) |
1.0 | 6.7 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
1.0 | 2.9 | GO:0042418 | epinephrine metabolic process(GO:0042414) epinephrine biosynthetic process(GO:0042418) |
1.0 | 15.3 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
1.0 | 2.9 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.9 | 0.9 | GO:0036466 | synaptic vesicle recycling via endosome(GO:0036466) |
0.9 | 1.9 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.9 | 10.4 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.9 | 1.9 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
0.9 | 29.8 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.9 | 5.6 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.9 | 5.6 | GO:0018377 | protein myristoylation(GO:0018377) |
0.9 | 4.6 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.9 | 0.9 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.9 | 2.7 | GO:0021722 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
0.9 | 3.6 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.9 | 4.5 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) Peyer's patch morphogenesis(GO:0061146) |
0.9 | 2.7 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.9 | 0.9 | GO:0015808 | L-alanine transport(GO:0015808) |
0.9 | 4.5 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.9 | 2.7 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.9 | 2.7 | GO:1904896 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
0.9 | 0.9 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.9 | 0.9 | GO:0033144 | negative regulation of intracellular steroid hormone receptor signaling pathway(GO:0033144) |
0.9 | 27.8 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.9 | 3.6 | GO:0021633 | optic nerve structural organization(GO:0021633) |
0.9 | 0.9 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
0.9 | 14.3 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.9 | 6.2 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.9 | 2.7 | GO:1902430 | negative regulation of beta-amyloid formation(GO:1902430) |
0.9 | 4.4 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.9 | 10.6 | GO:0019835 | cytolysis(GO:0019835) |
0.9 | 1.8 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
0.9 | 2.6 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.9 | 5.3 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.9 | 1.8 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.9 | 0.9 | GO:0046533 | negative regulation of photoreceptor cell differentiation(GO:0046533) |
0.9 | 1.8 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.9 | 7.9 | GO:0032364 | oxygen homeostasis(GO:0032364) |
0.9 | 3.5 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.9 | 36.8 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.9 | 5.2 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.9 | 5.2 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.9 | 7.0 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.9 | 3.5 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.9 | 10.4 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.9 | 1.7 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.9 | 8.7 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.9 | 2.6 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.9 | 1.7 | GO:0071104 | response to interleukin-9(GO:0071104) |
0.9 | 1.7 | GO:0043276 | anoikis(GO:0043276) |
0.9 | 1.7 | GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
0.9 | 7.7 | GO:0033227 | dsRNA transport(GO:0033227) |
0.9 | 5.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.9 | 8.5 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.8 | 5.1 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.8 | 3.4 | GO:0071313 | cellular response to caffeine(GO:0071313) |
0.8 | 2.5 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.8 | 1.7 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.8 | 2.5 | GO:1904530 | regulation of actin filament binding(GO:1904529) negative regulation of actin filament binding(GO:1904530) regulation of actin binding(GO:1904616) negative regulation of actin binding(GO:1904617) |
0.8 | 0.8 | GO:0060402 | cytosolic calcium ion transport(GO:0060401) calcium ion transport into cytosol(GO:0060402) |
0.8 | 21.0 | GO:0006536 | glutamate metabolic process(GO:0006536) |
0.8 | 5.0 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.8 | 1.7 | GO:0060214 | endocardium formation(GO:0060214) |
0.8 | 2.5 | GO:0071139 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
0.8 | 3.3 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
0.8 | 2.5 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.8 | 1.7 | GO:0030647 | glycoside metabolic process(GO:0016137) polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.8 | 4.9 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.8 | 9.8 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.8 | 0.8 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.8 | 1.6 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.8 | 1.6 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.8 | 0.8 | GO:0006907 | pinocytosis(GO:0006907) |
0.8 | 4.8 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.8 | 0.8 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.8 | 4.0 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.8 | 7.1 | GO:0060736 | prostate gland growth(GO:0060736) |
0.8 | 6.3 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.8 | 0.8 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.8 | 15.0 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.8 | 22.8 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.8 | 7.8 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.8 | 26.7 | GO:0050427 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.8 | 3.1 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.8 | 2.3 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.8 | 1.6 | GO:0071622 | regulation of granulocyte chemotaxis(GO:0071622) |
0.8 | 1.6 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.8 | 2.3 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) indolalkylamine biosynthetic process(GO:0046219) |
0.8 | 2.3 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.8 | 2.3 | GO:0042982 | amyloid precursor protein metabolic process(GO:0042982) |
0.8 | 14.7 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.8 | 1.5 | GO:0002363 | alpha-beta T cell lineage commitment(GO:0002363) |
0.8 | 3.9 | GO:1903423 | positive regulation of synaptic vesicle endocytosis(GO:1900244) positive regulation of synaptic vesicle recycling(GO:1903423) |
0.8 | 4.6 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.8 | 6.2 | GO:0009642 | response to light intensity(GO:0009642) |
0.8 | 9.3 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.8 | 1.5 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.8 | 1.5 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.8 | 6.9 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.8 | 1.5 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.8 | 6.1 | GO:0048243 | norepinephrine secretion(GO:0048243) |
0.8 | 3.8 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.8 | 9.9 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.8 | 2.3 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.8 | 11.4 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.8 | 1.5 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.8 | 1.5 | GO:0070221 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
0.8 | 1.5 | GO:1903509 | glycolipid metabolic process(GO:0006664) liposaccharide metabolic process(GO:1903509) |
0.8 | 0.8 | GO:0001820 | serotonin secretion(GO:0001820) |
0.8 | 3.0 | GO:0003335 | corneocyte development(GO:0003335) |
0.8 | 8.3 | GO:0001976 | neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
0.8 | 3.8 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.7 | 2.2 | GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
0.7 | 2.2 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
0.7 | 2.2 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.7 | 3.0 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.7 | 1.5 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.7 | 1.5 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.7 | 1.5 | GO:0009609 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
0.7 | 2.9 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.7 | 4.4 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.7 | 2.9 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
0.7 | 2.9 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.7 | 0.7 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.7 | 0.7 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
0.7 | 11.5 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.7 | 5.7 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.7 | 4.3 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.7 | 4.3 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.7 | 0.7 | GO:0015879 | amino-acid betaine transport(GO:0015838) carnitine transport(GO:0015879) |
0.7 | 2.8 | GO:0030822 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
0.7 | 2.1 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
0.7 | 2.1 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.7 | 5.6 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.7 | 3.5 | GO:0090042 | tubulin deacetylation(GO:0090042) |
0.7 | 11.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.7 | 11.2 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.7 | 5.6 | GO:0002003 | angiotensin maturation(GO:0002003) |
0.7 | 1.4 | GO:0001554 | luteolysis(GO:0001554) |
0.7 | 4.9 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.7 | 3.5 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.7 | 4.8 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.7 | 2.8 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.7 | 2.1 | GO:0045620 | negative regulation of lymphocyte differentiation(GO:0045620) |
0.7 | 8.9 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.7 | 21.2 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.7 | 2.1 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.7 | 3.4 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.7 | 2.7 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.7 | 1.4 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.7 | 2.7 | GO:0001977 | renal system process involved in regulation of blood volume(GO:0001977) |
0.7 | 4.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.7 | 4.1 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.7 | 0.7 | GO:0032735 | positive regulation of interleukin-12 production(GO:0032735) |
0.7 | 0.7 | GO:0032414 | positive regulation of ion transmembrane transporter activity(GO:0032414) |
0.7 | 8.8 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.7 | 2.7 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.7 | 2.7 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.7 | 5.4 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.7 | 1.3 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.7 | 4.0 | GO:0046465 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
0.7 | 16.1 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.7 | 17.3 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.7 | 5.3 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.7 | 4.0 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.7 | 1.3 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.7 | 1.3 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
0.7 | 19.2 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
0.7 | 1.3 | GO:0050957 | equilibrioception(GO:0050957) |
0.7 | 4.0 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.7 | 2.0 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.7 | 2.6 | GO:0051549 | positive regulation of keratinocyte migration(GO:0051549) |
0.7 | 2.0 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.7 | 3.9 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.7 | 0.7 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) |
0.6 | 9.7 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.6 | 1.9 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.6 | 1.9 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
0.6 | 1.3 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.6 | 1.9 | GO:0097484 | dendrite extension(GO:0097484) |
0.6 | 5.7 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.6 | 2.6 | GO:0051167 | glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
0.6 | 1.9 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.6 | 2.5 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.6 | 2.5 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
0.6 | 7.6 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.6 | 3.8 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
0.6 | 2.5 | GO:0015747 | urate transport(GO:0015747) |
0.6 | 1.9 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
0.6 | 1.3 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.6 | 3.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.6 | 5.0 | GO:0051601 | exocyst localization(GO:0051601) |
0.6 | 2.5 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.6 | 1.2 | GO:1900155 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
0.6 | 3.1 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.6 | 1.2 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.6 | 1.9 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.6 | 1.2 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.6 | 0.6 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.6 | 3.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.6 | 1.2 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.6 | 13.4 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.6 | 5.5 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
0.6 | 0.6 | GO:0060581 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
0.6 | 0.6 | GO:0032423 | regulation of mismatch repair(GO:0032423) positive regulation of mismatch repair(GO:0032425) |
0.6 | 4.2 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.6 | 3.0 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.6 | 1.8 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.6 | 3.0 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.6 | 1.8 | GO:0061536 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.6 | 1.8 | GO:0018065 | protein lipoylation(GO:0009249) protein-cofactor linkage(GO:0018065) |
0.6 | 0.6 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.6 | 0.6 | GO:0009078 | alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
0.6 | 0.6 | GO:0033197 | response to vitamin E(GO:0033197) |
0.6 | 4.1 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
0.6 | 1.2 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.6 | 0.6 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.6 | 1.2 | GO:0072131 | kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) nephrogenic mesenchyme morphogenesis(GO:0072134) |
0.6 | 2.3 | GO:0015816 | glycine transport(GO:0015816) |
0.6 | 5.8 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.6 | 4.6 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.6 | 2.3 | GO:0007320 | insemination(GO:0007320) |
0.6 | 1.7 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.6 | 1.2 | GO:1902723 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
0.6 | 10.3 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.6 | 2.9 | GO:0007498 | mesoderm development(GO:0007498) |
0.6 | 1.1 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.6 | 8.6 | GO:0098743 | cell aggregation(GO:0098743) |
0.6 | 1.1 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.6 | 1.7 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.6 | 1.7 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.6 | 4.0 | GO:0008016 | regulation of heart contraction(GO:0008016) |
0.6 | 2.8 | GO:0033668 | negative regulation by symbiont of host apoptotic process(GO:0033668) response to cycloheximide(GO:0046898) negative regulation by symbiont of host programmed cell death(GO:0052041) modulation by symbiont of host apoptotic process(GO:0052150) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.6 | 2.8 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.6 | 1.1 | GO:0009948 | anterior/posterior axis specification(GO:0009948) |
0.6 | 1.7 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) |
0.6 | 0.6 | GO:0046425 | regulation of JAK-STAT cascade(GO:0046425) regulation of STAT cascade(GO:1904892) |
0.6 | 1.7 | GO:0048593 | camera-type eye morphogenesis(GO:0048593) |
0.6 | 2.2 | GO:0002706 | regulation of lymphocyte mediated immunity(GO:0002706) |
0.6 | 2.2 | GO:0038042 | dimeric G-protein coupled receptor signaling pathway(GO:0038042) |
0.6 | 41.8 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.6 | 1.7 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.6 | 3.9 | GO:0097264 | self proteolysis(GO:0097264) |
0.6 | 0.6 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.6 | 1.7 | GO:0034201 | response to oleic acid(GO:0034201) |
0.6 | 0.6 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.6 | 2.8 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) tryptophan transport(GO:0015827) leucine import(GO:0060356) |
0.6 | 2.2 | GO:0010816 | neuropeptide catabolic process(GO:0010813) substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.5 | 1.1 | GO:0050729 | positive regulation of inflammatory response(GO:0050729) |
0.5 | 19.2 | GO:0006305 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.5 | 4.9 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.5 | 1.6 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
0.5 | 27.2 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.5 | 1.1 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.5 | 1.6 | GO:1904578 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) response to hypobaric hypoxia(GO:1990910) |
0.5 | 2.1 | GO:0001842 | neural fold formation(GO:0001842) |
0.5 | 8.0 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.5 | 4.8 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.5 | 3.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.5 | 1.1 | GO:0032429 | regulation of phospholipase A2 activity(GO:0032429) |
0.5 | 1.6 | GO:0045056 | transcytosis(GO:0045056) |
0.5 | 4.8 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
0.5 | 9.5 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.5 | 1.1 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.5 | 7.9 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.5 | 1.6 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.5 | 2.6 | GO:0071941 | nitrogen cycle metabolic process(GO:0071941) |
0.5 | 0.5 | GO:1902896 | intestinal D-glucose absorption(GO:0001951) terminal web assembly(GO:1902896) |
0.5 | 1.0 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) |
0.5 | 2.6 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.5 | 0.5 | GO:1903401 | L-lysine transmembrane transport(GO:1903401) |
0.5 | 3.1 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.5 | 3.1 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.5 | 2.0 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.5 | 0.5 | GO:1903487 | regulation of lactation(GO:1903487) |
0.5 | 2.0 | GO:0072402 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.5 | 0.5 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.5 | 1.5 | GO:0001757 | somite specification(GO:0001757) |
0.5 | 1.5 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.5 | 1.0 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.5 | 3.5 | GO:0008218 | bioluminescence(GO:0008218) |
0.5 | 4.0 | GO:0038034 | signal transduction in absence of ligand(GO:0038034) extrinsic apoptotic signaling pathway in absence of ligand(GO:0097192) |
0.5 | 1.5 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.5 | 2.0 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.5 | 19.7 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.5 | 1.0 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.5 | 2.5 | GO:0070875 | positive regulation of glycogen biosynthetic process(GO:0045725) positive regulation of glycogen metabolic process(GO:0070875) |
0.5 | 9.3 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.5 | 1.0 | GO:0072718 | response to cisplatin(GO:0072718) |
0.5 | 1.4 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
0.5 | 1.9 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.5 | 1.4 | GO:0019605 | benzoate metabolic process(GO:0018874) butyrate metabolic process(GO:0019605) |
0.5 | 0.5 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.5 | 4.8 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.5 | 6.2 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.5 | 1.0 | GO:0032328 | alanine transport(GO:0032328) |
0.5 | 1.0 | GO:0003007 | heart morphogenesis(GO:0003007) |
0.5 | 2.4 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.5 | 9.0 | GO:0019228 | neuronal action potential(GO:0019228) |
0.5 | 4.3 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
0.5 | 0.5 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.5 | 4.3 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.5 | 1.4 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.5 | 4.7 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.5 | 4.7 | GO:0017014 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.5 | 8.5 | GO:0003341 | cilium movement(GO:0003341) |
0.5 | 3.3 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.5 | 4.2 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.5 | 2.3 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.5 | 1.9 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
0.5 | 2.8 | GO:0050821 | protein stabilization(GO:0050821) |
0.5 | 2.8 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.5 | 1.8 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
0.5 | 8.3 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.5 | 1.4 | GO:0075071 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
0.5 | 2.7 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.5 | 1.4 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.5 | 5.9 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.5 | 5.0 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.5 | 6.4 | GO:0001754 | eye photoreceptor cell differentiation(GO:0001754) |
0.5 | 1.8 | GO:0007296 | vitellogenesis(GO:0007296) |
0.5 | 0.5 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.5 | 1.4 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.4 | 5.4 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.4 | 2.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.4 | 0.9 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.4 | 1.3 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.4 | 1.3 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
0.4 | 0.9 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.4 | 1.3 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.4 | 0.4 | GO:0060326 | cell chemotaxis(GO:0060326) |
0.4 | 1.3 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.4 | 4.3 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.4 | 10.3 | GO:0010107 | potassium ion import(GO:0010107) |
0.4 | 10.3 | GO:0031648 | protein destabilization(GO:0031648) |
0.4 | 1.3 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.4 | 4.3 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.4 | 0.4 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
0.4 | 0.4 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.4 | 1.7 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.4 | 1.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.4 | 0.4 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.4 | 2.9 | GO:0006828 | manganese ion transport(GO:0006828) |
0.4 | 1.6 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.4 | 0.8 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
0.4 | 2.8 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.4 | 1.2 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.4 | 2.8 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.4 | 0.8 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.4 | 4.4 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.4 | 2.0 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.4 | 1.2 | GO:1904823 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
0.4 | 1.2 | GO:0010842 | retina layer formation(GO:0010842) |
0.4 | 1.2 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.4 | 2.0 | GO:0009304 | tRNA transcription(GO:0009304) 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.4 | 4.3 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
0.4 | 2.7 | GO:0097354 | protein prenylation(GO:0018342) protein geranylgeranylation(GO:0018344) prenylation(GO:0097354) |
0.4 | 1.2 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.4 | 2.3 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
0.4 | 1.2 | GO:0048535 | lymph node development(GO:0048535) |
0.4 | 0.8 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.4 | 1.9 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
0.4 | 1.9 | GO:0045922 | negative regulation of fatty acid metabolic process(GO:0045922) |
0.4 | 13.4 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.4 | 3.8 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
0.4 | 1.1 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.4 | 1.1 | GO:0009107 | lipoate biosynthetic process(GO:0009107) |
0.4 | 2.3 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.4 | 3.4 | GO:2000209 | regulation of anoikis(GO:2000209) |
0.4 | 1.1 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.4 | 5.3 | GO:0097320 | membrane tubulation(GO:0097320) |
0.4 | 4.5 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) |
0.4 | 18.3 | GO:0050879 | multicellular organismal movement(GO:0050879) musculoskeletal movement(GO:0050881) |
0.4 | 4.1 | GO:0006491 | N-glycan processing(GO:0006491) |
0.4 | 1.1 | GO:0051194 | positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.4 | 0.7 | GO:0051155 | positive regulation of striated muscle cell differentiation(GO:0051155) |
0.4 | 1.5 | GO:0021759 | globus pallidus development(GO:0021759) |
0.4 | 1.8 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.4 | 1.8 | GO:0010761 | fibroblast migration(GO:0010761) |
0.4 | 2.5 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.4 | 0.4 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.4 | 1.1 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.4 | 0.4 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.4 | 4.6 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.4 | 5.7 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.4 | 1.4 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.4 | 1.1 | GO:0046125 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.4 | 0.4 | GO:0060947 | cardiac vascular smooth muscle cell differentiation(GO:0060947) |
0.4 | 1.1 | GO:0098937 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
0.4 | 1.4 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.4 | 0.4 | GO:0032986 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.3 | 4.2 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.3 | 1.4 | GO:0042755 | eating behavior(GO:0042755) |
0.3 | 3.4 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.3 | 0.3 | GO:0042938 | dipeptide transport(GO:0042938) |
0.3 | 1.0 | GO:1990502 | dense core granule maturation(GO:1990502) |
0.3 | 1.7 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.3 | 1.4 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.3 | 0.3 | GO:0038001 | paracrine signaling(GO:0038001) |
0.3 | 1.0 | GO:0048073 | regulation of eye pigmentation(GO:0048073) positive regulation of eye pigmentation(GO:0048075) |
0.3 | 1.7 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) |
0.3 | 3.4 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.3 | 4.7 | GO:0045199 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.3 | 1.7 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
0.3 | 1.0 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.3 | 3.3 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.3 | 2.3 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.3 | 0.3 | GO:0034445 | plasma lipoprotein particle oxidation(GO:0034441) regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
0.3 | 2.3 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.3 | 1.0 | GO:0055001 | muscle cell development(GO:0055001) |
0.3 | 0.7 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.3 | 0.7 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.3 | 11.8 | GO:0098760 | response to interleukin-7(GO:0098760) cellular response to interleukin-7(GO:0098761) |
0.3 | 2.0 | GO:0014894 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.3 | 3.6 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.3 | 2.3 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.3 | 0.6 | GO:0072071 | kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) |
0.3 | 1.0 | GO:0001207 | histone displacement(GO:0001207) regulation of transcription involved in meiotic cell cycle(GO:0051037) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
0.3 | 1.3 | GO:0007525 | somatic muscle development(GO:0007525) |
0.3 | 1.0 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.3 | 8.0 | GO:0051350 | negative regulation of lyase activity(GO:0051350) |
0.3 | 7.4 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.3 | 0.3 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.3 | 0.3 | GO:0034378 | chylomicron assembly(GO:0034378) |
0.3 | 10.1 | GO:0006968 | cellular defense response(GO:0006968) |
0.3 | 7.0 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.3 | 0.9 | GO:0090085 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) regulation of protein deubiquitination(GO:0090085) |
0.3 | 1.6 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.3 | 1.5 | GO:0010470 | regulation of gastrulation(GO:0010470) |
0.3 | 0.6 | GO:0001659 | temperature homeostasis(GO:0001659) |
0.3 | 1.2 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.3 | 0.9 | GO:0015791 | polyol transport(GO:0015791) |
0.3 | 1.5 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.3 | 0.9 | GO:0072017 | distal tubule development(GO:0072017) |
0.3 | 0.3 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.3 | 3.4 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
0.3 | 1.5 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.3 | 0.9 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.3 | 0.3 | GO:0035864 | response to potassium ion(GO:0035864) |
0.3 | 0.3 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.3 | 3.5 | GO:0032196 | transposition(GO:0032196) |
0.3 | 0.3 | GO:1902358 | sulfate transmembrane transport(GO:1902358) |
0.3 | 0.9 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.3 | 1.4 | GO:0048263 | determination of dorsal identity(GO:0048263) |
0.3 | 0.9 | GO:0031647 | regulation of protein stability(GO:0031647) |
0.3 | 1.2 | GO:0051567 | histone H3-K9 methylation(GO:0051567) |
0.3 | 4.0 | GO:1990823 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
0.3 | 3.1 | GO:0045598 | regulation of fat cell differentiation(GO:0045598) |
0.3 | 0.6 | GO:1903020 | positive regulation of glycoprotein metabolic process(GO:1903020) |
0.3 | 1.4 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.3 | 1.4 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.3 | 0.9 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.3 | 1.4 | GO:0051604 | protein maturation(GO:0051604) |
0.3 | 2.5 | GO:0006476 | protein deacetylation(GO:0006476) |
0.3 | 0.3 | GO:0019858 | cytosine metabolic process(GO:0019858) |
0.3 | 1.7 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.3 | 5.3 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.3 | 1.1 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.3 | 0.5 | GO:0051238 | sequestering of metal ion(GO:0051238) |
0.3 | 2.7 | GO:0044364 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
0.3 | 3.5 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.3 | 1.3 | GO:0060349 | bone morphogenesis(GO:0060349) |
0.3 | 0.5 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.3 | 2.7 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.3 | 0.8 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.3 | 15.7 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.3 | 0.5 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.3 | 0.8 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.3 | 1.3 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.3 | 0.3 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) vitamin D3 metabolic process(GO:0070640) |
0.3 | 2.1 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.3 | 1.8 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.3 | 0.3 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.3 | 0.8 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.3 | 1.3 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.3 | 0.3 | GO:0032273 | positive regulation of protein polymerization(GO:0032273) |
0.2 | 0.2 | GO:0036260 | 7-methylguanosine mRNA capping(GO:0006370) 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.2 | 0.5 | GO:0070459 | prolactin secretion(GO:0070459) |
0.2 | 1.0 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.2 | 2.2 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.2 | 2.2 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.2 | 1.9 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.2 | 11.0 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.2 | 0.7 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
0.2 | 1.9 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.2 | 1.0 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.2 | 0.5 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.2 | 3.6 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.2 | 8.1 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.2 | 1.7 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.2 | 0.5 | GO:0010458 | exit from mitosis(GO:0010458) |
0.2 | 2.1 | GO:0032715 | negative regulation of interleukin-6 production(GO:0032715) |
0.2 | 3.9 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.2 | 0.2 | GO:0042737 | drug catabolic process(GO:0042737) |
0.2 | 0.4 | GO:0034127 | regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034127) |
0.2 | 2.9 | GO:1901099 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.2 | 1.5 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.2 | 0.4 | GO:1904018 | positive regulation of vasculature development(GO:1904018) |
0.2 | 4.2 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.2 | 0.4 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.2 | 1.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.2 | 0.4 | GO:0071934 | thiamine transport(GO:0015888) thiamine transmembrane transport(GO:0071934) |
0.2 | 1.3 | GO:0098712 | L-glutamate import across plasma membrane(GO:0098712) |
0.2 | 0.4 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.2 | 0.4 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.2 | 2.3 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.2 | 0.6 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.2 | 0.2 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.2 | 0.4 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.2 | 0.6 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
0.2 | 0.4 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.2 | 0.4 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.2 | 0.6 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.2 | 0.6 | GO:0072249 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
0.2 | 3.6 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.2 | 15.9 | GO:0007586 | digestion(GO:0007586) |
0.2 | 1.0 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.2 | 0.8 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.2 | 0.8 | GO:0030903 | notochord development(GO:0030903) |
0.2 | 13.5 | GO:0098661 | inorganic anion transmembrane transport(GO:0098661) |
0.2 | 1.0 | GO:0014029 | neural crest formation(GO:0014029) |
0.2 | 2.6 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.2 | 1.2 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.2 | 1.0 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.2 | 1.8 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.2 | 1.0 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.2 | 0.4 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.2 | 0.2 | GO:0046368 | GDP-L-fucose biosynthetic process(GO:0042350) 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) GDP-L-fucose metabolic process(GO:0046368) |
0.2 | 1.1 | GO:0022405 | molting cycle process(GO:0022404) hair cycle process(GO:0022405) |
0.2 | 0.6 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
0.2 | 1.5 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.2 | 1.1 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.2 | 0.6 | GO:0072757 | cellular response to camptothecin(GO:0072757) response to camptothecin(GO:1901563) |
0.2 | 0.9 | GO:0030070 | insulin processing(GO:0030070) |
0.2 | 0.9 | GO:0014823 | response to activity(GO:0014823) |
0.2 | 1.1 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.2 | 0.2 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.2 | 0.2 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.2 | 0.2 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.2 | 0.5 | GO:0046440 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
0.2 | 0.5 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.2 | 0.7 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.2 | 1.1 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.2 | 0.4 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.2 | 4.1 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.2 | 0.5 | GO:0060431 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) primary lung bud formation(GO:0060431) lung induction(GO:0060492) regulation of branching involved in lung morphogenesis(GO:0061046) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.2 | 0.7 | GO:0050728 | negative regulation of inflammatory response(GO:0050728) |
0.2 | 0.9 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.2 | 0.2 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.2 | 1.2 | GO:0009650 | UV protection(GO:0009650) |
0.2 | 0.5 | GO:0090520 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
0.2 | 0.7 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.2 | 5.8 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.2 | 2.3 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.2 | 0.8 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.2 | 1.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.2 | 0.5 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.2 | 0.5 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.2 | 2.1 | GO:0030826 | regulation of cGMP biosynthetic process(GO:0030826) positive regulation of cGMP biosynthetic process(GO:0030828) |
0.2 | 0.6 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.2 | 1.7 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.2 | 0.5 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.2 | 0.5 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.2 | 0.9 | GO:1900372 | negative regulation of cyclic nucleotide biosynthetic process(GO:0030803) negative regulation of nucleotide biosynthetic process(GO:0030809) negative regulation of cAMP biosynthetic process(GO:0030818) negative regulation of purine nucleotide biosynthetic process(GO:1900372) |
0.2 | 0.6 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 3.6 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.1 | 4.6 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.7 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.4 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
0.1 | 3.9 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.1 | 0.7 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.1 | 3.1 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.4 | GO:0035150 | regulation of tube size(GO:0035150) regulation of blood vessel size(GO:0050880) |
0.1 | 19.5 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 0.3 | GO:0032305 | positive regulation of icosanoid secretion(GO:0032305) positive regulation of fatty acid transport(GO:2000193) |
0.1 | 0.4 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.1 | 2.7 | GO:0061013 | regulation of mRNA catabolic process(GO:0061013) |
0.1 | 1.1 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.1 | 0.3 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 0.3 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.1 | 0.3 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 0.8 | GO:0090659 | walking behavior(GO:0090659) |
0.1 | 1.2 | GO:0030238 | male sex determination(GO:0030238) |
0.1 | 2.9 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
0.1 | 2.3 | GO:0060350 | endochondral bone morphogenesis(GO:0060350) |
0.1 | 0.9 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.1 | 0.1 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.1 | 0.7 | GO:0007595 | lactation(GO:0007595) |
0.1 | 1.0 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.1 | 1.0 | GO:0007512 | adult heart development(GO:0007512) |
0.1 | 0.4 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.1 | 1.2 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
0.1 | 0.7 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.1 | 0.6 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 1.3 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 0.7 | GO:0035411 | catenin import into nucleus(GO:0035411) |
0.1 | 0.8 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
0.1 | 0.8 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.1 | 0.5 | GO:0061430 | bone trabecula morphogenesis(GO:0061430) |
0.1 | 0.3 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.1 | 0.2 | GO:0032228 | regulation of synaptic transmission, GABAergic(GO:0032228) |
0.1 | 0.3 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.1 | 0.1 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.1 | 1.1 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.1 | 1.1 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.7 | GO:0086091 | regulation of heart rate by cardiac conduction(GO:0086091) |
0.1 | 2.3 | GO:0071357 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.1 | 0.2 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.1 | 0.3 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.1 | 0.3 | GO:0050757 | thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) |
0.1 | 0.3 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
0.1 | 3.4 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.1 | 0.7 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.1 | 0.1 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.1 | 0.4 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.1 | 0.4 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 0.2 | GO:0048665 | neuron fate specification(GO:0048665) |
0.1 | 0.3 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.1 | 1.0 | GO:0001541 | ovarian follicle development(GO:0001541) |
0.1 | 0.2 | GO:0016240 | autophagosome docking(GO:0016240) |
0.1 | 0.7 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.1 | 0.8 | GO:0018195 | peptidyl-arginine modification(GO:0018195) |
0.1 | 1.0 | GO:0090311 | regulation of protein deacetylation(GO:0090311) |
0.1 | 0.2 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.1 | 1.4 | GO:0034113 | heterotypic cell-cell adhesion(GO:0034113) |
0.1 | 0.8 | GO:0007405 | neuroblast proliferation(GO:0007405) |
0.1 | 0.1 | GO:0046643 | regulation of gamma-delta T cell activation(GO:0046643) |
0.1 | 1.2 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 4.7 | GO:0070268 | cornification(GO:0070268) |
0.1 | 0.1 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.1 | 1.3 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.1 | 0.5 | GO:0033077 | T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
0.1 | 0.9 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.1 | 0.2 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.1 | 28.3 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.1 | 0.9 | GO:0001837 | epithelial to mesenchymal transition(GO:0001837) |
0.1 | 0.8 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.1 | 0.2 | GO:0008356 | asymmetric cell division(GO:0008356) |
0.1 | 0.7 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.2 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 0.3 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.1 | 0.1 | GO:0048627 | myoblast development(GO:0048627) |
0.1 | 1.1 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.0 | 0.1 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.0 | 0.2 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.0 | 0.2 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.0 | 0.1 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
0.0 | 0.4 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.0 | 1.8 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 0.1 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.0 | 0.4 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.0 | 0.3 | GO:0030050 | vesicle transport along actin filament(GO:0030050) actin filament-based transport(GO:0099515) |
0.0 | 1.2 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.0 | 0.2 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.0 | 0.9 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.0 | 0.1 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.0 | 0.1 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
0.0 | 0.1 | GO:0048469 | cell maturation(GO:0048469) |
0.0 | 0.0 | GO:0033762 | response to glucagon(GO:0033762) |
0.0 | 0.1 | GO:0097056 | seryl-tRNA aminoacylation(GO:0006434) selenocysteinyl-tRNA(Sec) biosynthetic process(GO:0097056) |
0.0 | 0.5 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.0 | 0.5 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 0.3 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
0.0 | 0.1 | GO:0098727 | maintenance of cell number(GO:0098727) |
0.0 | 0.1 | GO:0055074 | calcium ion homeostasis(GO:0055074) |
0.0 | 0.1 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.0 | 0.3 | GO:0046949 | fatty-acyl-CoA biosynthetic process(GO:0046949) |
0.0 | 0.1 | GO:1901877 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
0.0 | 0.2 | GO:0048511 | rhythmic process(GO:0048511) |
0.0 | 0.2 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
0.0 | 0.0 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.1 | GO:0097359 | UDP-glucosylation(GO:0097359) |
0.0 | 0.2 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.0 | 0.2 | GO:0007398 | ectoderm development(GO:0007398) |
0.0 | 0.0 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.0 | 0.0 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.0 | 0.1 | GO:0021930 | cell proliferation in hindbrain(GO:0021534) cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.0 | 0.2 | GO:0046606 | negative regulation of centrosome cycle(GO:0046606) |
0.0 | 0.1 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
0.0 | 0.0 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.0 | 0.1 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.0 | 0.1 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
81.0 | 242.9 | GO:0071749 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
15.1 | 708.9 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
11.5 | 241.9 | GO:0042613 | MHC class II protein complex(GO:0042613) |
9.1 | 36.2 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
8.0 | 47.9 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
7.9 | 39.6 | GO:0001652 | granular component(GO:0001652) |
7.3 | 43.8 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
7.3 | 36.4 | GO:0005602 | complement component C1 complex(GO:0005602) |
7.1 | 21.2 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
6.9 | 76.4 | GO:0042611 | MHC protein complex(GO:0042611) |
6.6 | 39.6 | GO:0005927 | muscle tendon junction(GO:0005927) |
6.2 | 43.4 | GO:0019815 | B cell receptor complex(GO:0019815) |
5.6 | 39.2 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
5.6 | 44.5 | GO:0032010 | phagolysosome(GO:0032010) |
5.5 | 60.7 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
5.3 | 32.0 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
5.3 | 42.1 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
5.3 | 21.0 | GO:0043293 | apoptosome(GO:0043293) |
4.9 | 14.7 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
4.3 | 25.9 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
3.9 | 15.8 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
3.8 | 34.3 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
3.7 | 11.2 | GO:0036030 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
3.6 | 25.0 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
3.6 | 14.3 | GO:0044194 | cytolytic granule(GO:0044194) |
3.5 | 28.0 | GO:0005833 | hemoglobin complex(GO:0005833) |
3.4 | 41.2 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
3.4 | 20.4 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
3.3 | 562.5 | GO:0072562 | blood microparticle(GO:0072562) |
3.2 | 42.0 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
3.0 | 6.1 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
2.9 | 5.9 | GO:0098576 | lumenal side of membrane(GO:0098576) |
2.9 | 8.8 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
2.9 | 14.3 | GO:0036398 | TCR signalosome(GO:0036398) |
2.8 | 2.8 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
2.7 | 8.2 | GO:0031251 | PAN complex(GO:0031251) |
2.7 | 37.6 | GO:0042627 | chylomicron(GO:0042627) |
2.7 | 16.1 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
2.7 | 21.5 | GO:0045179 | apical cortex(GO:0045179) |
2.7 | 2.7 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
2.6 | 7.7 | GO:0044609 | DBIRD complex(GO:0044609) |
2.5 | 15.3 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
2.2 | 6.5 | GO:0044305 | calyx of Held(GO:0044305) |
2.1 | 44.5 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
2.1 | 6.3 | GO:0005921 | gap junction(GO:0005921) |
2.1 | 12.5 | GO:1990037 | Lewy body core(GO:1990037) |
2.1 | 6.2 | GO:0002139 | stereocilia coupling link(GO:0002139) |
2.1 | 10.3 | GO:0071546 | pi-body(GO:0071546) |
2.0 | 12.1 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
2.0 | 8.0 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
2.0 | 37.9 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
2.0 | 9.9 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
2.0 | 23.5 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
2.0 | 5.9 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
1.9 | 11.4 | GO:1990130 | Iml1 complex(GO:1990130) |
1.8 | 31.2 | GO:0001891 | phagocytic cup(GO:0001891) |
1.8 | 14.6 | GO:0036157 | outer dynein arm(GO:0036157) |
1.8 | 9.0 | GO:0000801 | central element(GO:0000801) |
1.7 | 8.7 | GO:0000836 | Hrd1p ubiquitin ligase complex(GO:0000836) |
1.7 | 6.8 | GO:0097443 | sorting endosome(GO:0097443) |
1.7 | 6.8 | GO:0070695 | FHF complex(GO:0070695) |
1.7 | 13.3 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
1.7 | 6.6 | GO:1990745 | EARP complex(GO:1990745) |
1.6 | 13.0 | GO:0033391 | chromatoid body(GO:0033391) |
1.6 | 11.4 | GO:0072687 | meiotic spindle(GO:0072687) |
1.6 | 60.0 | GO:0005859 | muscle myosin complex(GO:0005859) |
1.6 | 9.7 | GO:1990769 | proximal neuron projection(GO:1990769) |
1.6 | 6.4 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
1.5 | 10.6 | GO:0097165 | nuclear stress granule(GO:0097165) |
1.5 | 6.0 | GO:0032009 | early phagosome(GO:0032009) |
1.5 | 10.5 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
1.5 | 10.3 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
1.4 | 7.2 | GO:0043194 | axon initial segment(GO:0043194) |
1.4 | 11.5 | GO:0043203 | axon hillock(GO:0043203) |
1.4 | 9.9 | GO:0000813 | ESCRT I complex(GO:0000813) |
1.4 | 5.6 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
1.4 | 4.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
1.4 | 11.0 | GO:0044666 | MLL3/4 complex(GO:0044666) |
1.3 | 8.1 | GO:0042825 | TAP complex(GO:0042825) |
1.3 | 8.0 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
1.3 | 15.7 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
1.3 | 17.0 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
1.3 | 20.8 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
1.3 | 22.7 | GO:0005861 | troponin complex(GO:0005861) |
1.3 | 6.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
1.3 | 10.0 | GO:0035976 | AP1 complex(GO:0035976) |
1.2 | 12.5 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
1.2 | 1.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
1.2 | 25.9 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
1.2 | 2.5 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
1.2 | 3.7 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
1.2 | 1.2 | GO:0042827 | platelet dense granule membrane(GO:0031088) platelet dense granule(GO:0042827) |
1.2 | 7.3 | GO:0005858 | axonemal dynein complex(GO:0005858) |
1.2 | 3.6 | GO:0097489 | multivesicular body, internal vesicle lumen(GO:0097489) |
1.2 | 3.6 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
1.2 | 4.8 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
1.2 | 3.6 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
1.2 | 3.6 | GO:0030008 | TRAPP complex(GO:0030008) |
1.2 | 4.7 | GO:0031085 | BLOC-3 complex(GO:0031085) |
1.2 | 3.5 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
1.1 | 5.7 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
1.1 | 11.3 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
1.1 | 3.4 | GO:0034657 | GID complex(GO:0034657) |
1.1 | 6.6 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
1.1 | 4.4 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
1.1 | 2.2 | GO:0043159 | acrosomal matrix(GO:0043159) |
1.1 | 7.6 | GO:0016461 | unconventional myosin complex(GO:0016461) |
1.1 | 2.2 | GO:0097209 | epidermal lamellar body(GO:0097209) |
1.1 | 6.5 | GO:0005577 | fibrinogen complex(GO:0005577) |
1.1 | 3.2 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
1.1 | 7.5 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
1.1 | 136.0 | GO:0005796 | Golgi lumen(GO:0005796) |
1.1 | 3.2 | GO:0098536 | deuterosome(GO:0098536) |
1.0 | 4.0 | GO:0097513 | myosin II filament(GO:0097513) |
1.0 | 8.9 | GO:0016013 | syntrophin complex(GO:0016013) |
1.0 | 17.6 | GO:0031932 | TORC2 complex(GO:0031932) |
1.0 | 3.9 | GO:0055087 | Ski complex(GO:0055087) |
1.0 | 9.7 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
1.0 | 90.5 | GO:0043202 | lysosomal lumen(GO:0043202) |
1.0 | 6.7 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.9 | 2.8 | GO:1990635 | proximal dendrite(GO:1990635) |
0.9 | 8.4 | GO:0034464 | BBSome(GO:0034464) |
0.9 | 8.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.9 | 4.5 | GO:0060091 | kinocilium(GO:0060091) |
0.9 | 3.6 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
0.9 | 28.8 | GO:0008305 | integrin complex(GO:0008305) |
0.9 | 30.3 | GO:0042629 | mast cell granule(GO:0042629) |
0.9 | 4.4 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.9 | 2.6 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.9 | 1.7 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.9 | 6.0 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.9 | 2.6 | GO:0070938 | contractile ring(GO:0070938) |
0.8 | 21.1 | GO:0034706 | sodium channel complex(GO:0034706) |
0.8 | 66.4 | GO:0034707 | chloride channel complex(GO:0034707) |
0.8 | 9.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.8 | 5.7 | GO:0097361 | CIA complex(GO:0097361) |
0.8 | 1.6 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.8 | 4.7 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.8 | 65.7 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.8 | 1.5 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.8 | 7.6 | GO:0097486 | multivesicular body lumen(GO:0097486) |
0.8 | 12.2 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.8 | 1.5 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.7 | 3.0 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.7 | 3.7 | GO:0005579 | membrane attack complex(GO:0005579) |
0.7 | 43.2 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.7 | 5.0 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.7 | 7.0 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.7 | 2.1 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
0.7 | 3.5 | GO:0089701 | U2AF(GO:0089701) |
0.7 | 3.5 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.7 | 9.6 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.7 | 2.7 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.7 | 10.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.7 | 2.7 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.7 | 13.4 | GO:0034451 | centriolar satellite(GO:0034451) |
0.7 | 5.4 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.7 | 6.0 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.7 | 147.1 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.7 | 2.6 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.7 | 3.3 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.6 | 5.1 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.6 | 0.6 | GO:0032982 | myosin filament(GO:0032982) |
0.6 | 1.9 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.6 | 8.7 | GO:0035102 | PRC1 complex(GO:0035102) |
0.6 | 10.1 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.6 | 4.2 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.6 | 3.0 | GO:0016342 | catenin complex(GO:0016342) |
0.6 | 51.2 | GO:0035579 | specific granule membrane(GO:0035579) |
0.6 | 5.3 | GO:0070652 | HAUS complex(GO:0070652) |
0.6 | 1.7 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
0.6 | 60.9 | GO:0034705 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
0.6 | 35.0 | GO:0005902 | microvillus(GO:0005902) |
0.6 | 2.8 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.6 | 1.7 | GO:0044423 | virion(GO:0019012) virion part(GO:0044423) |
0.6 | 3.4 | GO:0042588 | zymogen granule(GO:0042588) |
0.6 | 2.2 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
0.5 | 2.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.5 | 0.5 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
0.5 | 1.6 | GO:0030870 | Mre11 complex(GO:0030870) |
0.5 | 5.4 | GO:0097427 | microtubule bundle(GO:0097427) |
0.5 | 11.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.5 | 3.8 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.5 | 5.9 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.5 | 9.1 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.5 | 3.2 | GO:0032590 | dendrite membrane(GO:0032590) |
0.5 | 4.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.5 | 2.6 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.5 | 2.6 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.5 | 1.0 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.5 | 12.2 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.5 | 9.1 | GO:0030175 | filopodium(GO:0030175) |
0.5 | 1.5 | GO:1990393 | 3M complex(GO:1990393) |
0.5 | 3.0 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.5 | 2.0 | GO:0070081 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
0.5 | 23.6 | GO:0001533 | cornified envelope(GO:0001533) |
0.5 | 2.9 | GO:0071953 | elastic fiber(GO:0071953) |
0.5 | 12.2 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.5 | 1.5 | GO:0097413 | Lewy body(GO:0097413) |
0.5 | 49.0 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.5 | 569.9 | GO:0005615 | extracellular space(GO:0005615) |
0.5 | 1.4 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.5 | 9.1 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.5 | 6.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.4 | 4.5 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.4 | 5.2 | GO:0005642 | annulate lamellae(GO:0005642) |
0.4 | 2.6 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.4 | 6.9 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.4 | 5.9 | GO:0000242 | pericentriolar material(GO:0000242) |
0.4 | 45.8 | GO:0032587 | ruffle membrane(GO:0032587) |
0.4 | 2.0 | GO:0070826 | paraferritin complex(GO:0070826) |
0.4 | 1.6 | GO:0032584 | growth cone membrane(GO:0032584) |
0.4 | 4.9 | GO:0016580 | Sin3 complex(GO:0016580) |
0.4 | 0.4 | GO:0043196 | varicosity(GO:0043196) |
0.4 | 27.2 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.4 | 3.4 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.4 | 48.5 | GO:0016605 | PML body(GO:0016605) |
0.4 | 4.5 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.4 | 10.5 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.4 | 3.4 | GO:0031527 | filopodium membrane(GO:0031527) |
0.4 | 1.5 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.4 | 1.1 | GO:0031213 | RSF complex(GO:0031213) |
0.4 | 1.4 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.3 | 2.8 | GO:0031045 | dense core granule(GO:0031045) |
0.3 | 4.5 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.3 | 1.4 | GO:0030936 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
0.3 | 7.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.3 | 8.1 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.3 | 2.3 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.3 | 1.6 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.3 | 3.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.3 | 2.3 | GO:0072487 | MSL complex(GO:0072487) |
0.3 | 1.9 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.3 | 8.5 | GO:0005581 | collagen trimer(GO:0005581) |
0.3 | 1.9 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.3 | 2.2 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.3 | 10.1 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.3 | 3.1 | GO:0001741 | XY body(GO:0001741) |
0.3 | 0.6 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.3 | 3.1 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.3 | 2.2 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.3 | 2.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.3 | 1.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.3 | 408.8 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
0.3 | 1.8 | GO:0001520 | outer dense fiber(GO:0001520) |
0.3 | 1.2 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.3 | 1.2 | GO:0045298 | tubulin complex(GO:0045298) |
0.3 | 10.1 | GO:0000786 | nucleosome(GO:0000786) |
0.3 | 1.4 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.3 | 1.7 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.3 | 8.5 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.3 | 1.1 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.3 | 13.2 | GO:0030133 | transport vesicle(GO:0030133) |
0.3 | 1.4 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.3 | 3.3 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.3 | 29.2 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.3 | 0.8 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.2 | 0.5 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
0.2 | 1.2 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.2 | 26.8 | GO:0030427 | site of polarized growth(GO:0030427) |
0.2 | 0.2 | GO:1903349 | omegasome membrane(GO:1903349) |
0.2 | 9.4 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.2 | 6.4 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.2 | 1.4 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 13.1 | GO:0001726 | ruffle(GO:0001726) |
0.2 | 31.2 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.2 | 7.2 | GO:0016459 | myosin complex(GO:0016459) |
0.2 | 0.8 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
0.2 | 1.4 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.2 | 2.1 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.2 | 9.9 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.2 | 0.8 | GO:0071797 | LUBAC complex(GO:0071797) |
0.2 | 4.1 | GO:0098793 | presynapse(GO:0098793) |
0.2 | 12.4 | GO:0043204 | perikaryon(GO:0043204) |
0.2 | 1.6 | GO:0032039 | integrator complex(GO:0032039) |
0.2 | 0.3 | GO:0033011 | perinuclear theca(GO:0033011) cytoskeletal calyx(GO:0033150) |
0.1 | 0.6 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 1.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 1.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 5.2 | GO:0005923 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.1 | 1.2 | GO:0044754 | autolysosome(GO:0044754) |
0.1 | 1.4 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 0.9 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.1 | 0.8 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 3.6 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 2.6 | GO:0090568 | nuclear transcriptional repressor complex(GO:0090568) |
0.1 | 1.1 | GO:0031904 | endosome lumen(GO:0031904) |
0.1 | 0.3 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.1 | 0.5 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 2.3 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 1.3 | GO:0071565 | nBAF complex(GO:0071565) |
0.1 | 0.1 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.1 | 0.9 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 0.2 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 1.5 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 10.1 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 5.7 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 1.9 | GO:0043235 | receptor complex(GO:0043235) |
0.0 | 0.5 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.7 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.1 | GO:0098845 | postsynaptic endosome(GO:0098845) |
0.0 | 0.2 | GO:0070847 | core mediator complex(GO:0070847) |
0.0 | 0.8 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 6.8 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 0.1 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 0.0 | GO:0001740 | Barr body(GO:0001740) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
17.1 | 939.9 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
13.1 | 39.2 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
11.9 | 35.6 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) |
10.2 | 30.7 | GO:0090556 | apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
8.9 | 62.4 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
7.5 | 286.5 | GO:0042605 | peptide antigen binding(GO:0042605) |
7.5 | 22.6 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
7.3 | 43.8 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
7.2 | 21.6 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
6.7 | 20.0 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
6.5 | 26.1 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
6.5 | 25.9 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
6.3 | 62.9 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
6.3 | 18.8 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
6.1 | 36.6 | GO:0030492 | hemoglobin binding(GO:0030492) |
6.1 | 30.5 | GO:0042289 | MHC class II protein binding(GO:0042289) |
6.1 | 18.3 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
5.8 | 35.0 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
5.8 | 28.9 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
5.6 | 16.9 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
5.3 | 10.6 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
5.3 | 57.9 | GO:0005344 | oxygen transporter activity(GO:0005344) |
5.3 | 42.1 | GO:0030172 | troponin C binding(GO:0030172) |
5.1 | 20.5 | GO:0019862 | IgA binding(GO:0019862) |
5.1 | 15.2 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
5.0 | 20.1 | GO:0008431 | vitamin E binding(GO:0008431) |
5.0 | 14.9 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
4.9 | 19.8 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
4.9 | 44.2 | GO:0043426 | MRF binding(GO:0043426) |
4.9 | 19.6 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
4.9 | 14.6 | GO:0004103 | choline kinase activity(GO:0004103) |
4.7 | 14.1 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
4.7 | 18.6 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
4.7 | 18.6 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
4.6 | 667.3 | GO:0003823 | antigen binding(GO:0003823) |
4.6 | 36.5 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
4.5 | 22.7 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
4.5 | 4.5 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
4.4 | 13.2 | GO:0019959 | interleukin-8 binding(GO:0019959) |
4.3 | 21.5 | GO:0071723 | lipopeptide binding(GO:0071723) |
4.2 | 21.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
4.1 | 8.3 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
4.1 | 20.3 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
4.1 | 16.2 | GO:0031685 | adenosine receptor binding(GO:0031685) |
4.0 | 12.1 | GO:0017129 | triglyceride binding(GO:0017129) |
4.0 | 32.0 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
4.0 | 12.0 | GO:0047150 | betaine-homocysteine S-methyltransferase activity(GO:0047150) |
3.9 | 11.8 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
3.9 | 11.6 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
3.8 | 15.4 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
3.8 | 15.2 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
3.7 | 18.7 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
3.7 | 11.2 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
3.7 | 11.1 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
3.7 | 18.5 | GO:0001129 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
3.7 | 14.7 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
3.7 | 18.3 | GO:0031013 | troponin I binding(GO:0031013) |
3.6 | 32.8 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
3.6 | 3.6 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
3.5 | 14.1 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
3.5 | 28.1 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
3.5 | 17.4 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
3.5 | 17.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
3.4 | 10.3 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
3.4 | 13.7 | GO:0004803 | transposase activity(GO:0004803) |
3.4 | 13.5 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
3.3 | 13.0 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
3.2 | 56.8 | GO:0019992 | diacylglycerol binding(GO:0019992) |
3.1 | 37.6 | GO:0042608 | T cell receptor binding(GO:0042608) |
3.1 | 9.4 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
3.1 | 15.5 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
3.1 | 6.2 | GO:0019770 | IgG receptor activity(GO:0019770) |
3.1 | 9.2 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
3.1 | 9.2 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
3.0 | 12.1 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
3.0 | 11.9 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
2.9 | 17.6 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
2.9 | 55.0 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
2.9 | 31.4 | GO:0008430 | selenium binding(GO:0008430) |
2.8 | 8.5 | GO:0015131 | thiosulfate transmembrane transporter activity(GO:0015117) oxaloacetate transmembrane transporter activity(GO:0015131) |
2.8 | 22.6 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
2.8 | 30.7 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
2.8 | 16.6 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
2.8 | 8.3 | GO:0008941 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
2.7 | 8.2 | GO:0042806 | fucose binding(GO:0042806) |
2.7 | 10.8 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
2.7 | 13.4 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
2.7 | 34.6 | GO:0019957 | C-C chemokine binding(GO:0019957) |
2.7 | 8.0 | GO:0034584 | piRNA binding(GO:0034584) |
2.6 | 31.7 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
2.6 | 10.5 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
2.6 | 7.8 | GO:0036134 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
2.6 | 10.4 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
2.6 | 5.2 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
2.6 | 15.5 | GO:0004522 | ribonuclease A activity(GO:0004522) |
2.6 | 2.6 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
2.6 | 15.3 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
2.5 | 10.2 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
2.5 | 15.2 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
2.5 | 7.6 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
2.5 | 2.5 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
2.5 | 17.5 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
2.5 | 20.0 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
2.5 | 27.2 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
2.5 | 42.0 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
2.4 | 19.5 | GO:0034235 | GPI anchor binding(GO:0034235) |
2.4 | 9.7 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
2.4 | 43.6 | GO:0070330 | aromatase activity(GO:0070330) |
2.4 | 9.7 | GO:0016160 | amylase activity(GO:0016160) |
2.4 | 4.8 | GO:0016936 | galactoside binding(GO:0016936) |
2.4 | 14.5 | GO:0003796 | lysozyme activity(GO:0003796) |
2.4 | 9.6 | GO:0061714 | folic acid receptor activity(GO:0061714) |
2.4 | 7.2 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) |
2.4 | 14.3 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
2.4 | 14.3 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
2.4 | 2.4 | GO:0050436 | microfibril binding(GO:0050436) |
2.4 | 9.5 | GO:0070051 | fibrinogen binding(GO:0070051) |
2.4 | 9.4 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
2.3 | 7.0 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
2.3 | 7.0 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
2.3 | 25.6 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
2.3 | 9.3 | GO:0097001 | ceramide binding(GO:0097001) |
2.3 | 18.5 | GO:0070324 | thyroid hormone binding(GO:0070324) |
2.3 | 9.1 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
2.3 | 2.3 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
2.2 | 6.7 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) NAD(P)+ nucleosidase activity(GO:0050135) |
2.2 | 22.5 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
2.2 | 22.4 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
2.2 | 6.7 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
2.2 | 2.2 | GO:0015925 | galactosidase activity(GO:0015925) |
2.2 | 6.7 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
2.2 | 8.8 | GO:0001855 | complement component C4b binding(GO:0001855) |
2.2 | 6.5 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
2.2 | 6.5 | GO:0001181 | transcription factor activity, core RNA polymerase I binding(GO:0001181) |
2.2 | 21.6 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
2.2 | 6.5 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
2.1 | 17.1 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
2.1 | 25.3 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
2.1 | 61.1 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
2.1 | 8.4 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
2.1 | 23.1 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
2.0 | 8.2 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
2.0 | 8.1 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
2.0 | 2.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
2.0 | 6.0 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
2.0 | 6.0 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
2.0 | 4.0 | GO:0005230 | extracellular ligand-gated ion channel activity(GO:0005230) |
2.0 | 13.9 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
2.0 | 5.9 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
2.0 | 5.9 | GO:0051139 | metal ion:proton antiporter activity(GO:0051139) |
2.0 | 5.9 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
2.0 | 7.8 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
1.9 | 9.7 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
1.9 | 11.6 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
1.9 | 13.4 | GO:0001515 | opioid peptide activity(GO:0001515) |
1.9 | 5.7 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
1.9 | 13.2 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
1.9 | 9.4 | GO:0004771 | sterol esterase activity(GO:0004771) |
1.9 | 26.2 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
1.9 | 194.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
1.9 | 24.2 | GO:0019841 | retinol binding(GO:0019841) |
1.9 | 29.6 | GO:0003680 | AT DNA binding(GO:0003680) |
1.8 | 3.7 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
1.8 | 1.8 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
1.8 | 9.0 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
1.8 | 14.3 | GO:0045159 | myosin II binding(GO:0045159) |
1.8 | 5.3 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
1.8 | 10.7 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
1.8 | 5.3 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
1.8 | 7.1 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
1.8 | 7.0 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
1.7 | 3.5 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
1.7 | 31.0 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
1.7 | 18.6 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.7 | 3.4 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
1.7 | 16.9 | GO:0008061 | chitinase activity(GO:0004568) chitin binding(GO:0008061) |
1.7 | 5.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
1.7 | 375.2 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
1.7 | 3.4 | GO:0004515 | nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
1.7 | 18.3 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
1.7 | 5.0 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
1.7 | 8.3 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
1.7 | 9.9 | GO:0004630 | phospholipase D activity(GO:0004630) |
1.6 | 4.9 | GO:0015361 | low-affinity sodium:dicarboxylate symporter activity(GO:0015361) |
1.6 | 9.8 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
1.6 | 27.8 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
1.6 | 8.2 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
1.6 | 22.8 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
1.6 | 1.6 | GO:0051373 | FATZ binding(GO:0051373) |
1.6 | 6.5 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
1.6 | 8.1 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
1.6 | 4.9 | GO:1904288 | BAT3 complex binding(GO:1904288) |
1.6 | 27.4 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
1.6 | 11.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
1.6 | 1.6 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
1.6 | 6.3 | GO:0008940 | nitrate reductase activity(GO:0008940) |
1.6 | 4.7 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
1.6 | 48.5 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
1.6 | 1.6 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
1.6 | 4.7 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
1.5 | 4.5 | GO:0032090 | Pyrin domain binding(GO:0032090) |
1.5 | 21.1 | GO:0003993 | acid phosphatase activity(GO:0003993) |
1.5 | 10.5 | GO:0097643 | amylin receptor activity(GO:0097643) |
1.5 | 10.5 | GO:0050693 | LBD domain binding(GO:0050693) |
1.5 | 13.5 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
1.5 | 10.4 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
1.5 | 5.9 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
1.5 | 20.8 | GO:0019864 | IgG binding(GO:0019864) |
1.5 | 2.9 | GO:0015265 | urea channel activity(GO:0015265) |
1.5 | 4.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
1.5 | 7.3 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
1.5 | 2.9 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
1.5 | 14.6 | GO:0031433 | telethonin binding(GO:0031433) |
1.5 | 5.8 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
1.4 | 13.0 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
1.4 | 4.3 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
1.4 | 2.9 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
1.4 | 4.3 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
1.4 | 24.1 | GO:0038191 | neuropilin binding(GO:0038191) |
1.4 | 2.8 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
1.4 | 4.2 | GO:0031812 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
1.4 | 9.8 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
1.4 | 8.4 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
1.4 | 4.2 | GO:0005174 | CD40 receptor binding(GO:0005174) |
1.4 | 11.2 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
1.4 | 14.0 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
1.4 | 41.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
1.4 | 5.5 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
1.4 | 9.6 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
1.4 | 5.5 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
1.4 | 19.0 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
1.4 | 4.1 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
1.4 | 5.4 | GO:0035939 | microsatellite binding(GO:0035939) |
1.3 | 4.0 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
1.3 | 4.0 | GO:0001003 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
1.3 | 4.0 | GO:0001847 | opsonin receptor activity(GO:0001847) |
1.3 | 4.0 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
1.3 | 4.0 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
1.3 | 4.0 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
1.3 | 11.8 | GO:0042609 | CD4 receptor binding(GO:0042609) |
1.3 | 5.2 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
1.3 | 1.3 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
1.3 | 10.4 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
1.3 | 11.6 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
1.3 | 9.0 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
1.3 | 6.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
1.3 | 1.3 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
1.3 | 14.0 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
1.3 | 3.8 | GO:0016749 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
1.2 | 7.5 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
1.2 | 3.7 | GO:0032093 | SAM domain binding(GO:0032093) |
1.2 | 7.4 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
1.2 | 2.5 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
1.2 | 4.9 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.2 | 22.0 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
1.2 | 2.4 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
1.2 | 4.8 | GO:0015254 | glycerol channel activity(GO:0015254) |
1.2 | 6.0 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
1.2 | 13.0 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
1.2 | 21.3 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
1.2 | 3.5 | GO:0008106 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) alcohol dehydrogenase (NADP+) activity(GO:0008106) |
1.2 | 5.8 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
1.2 | 4.7 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
1.2 | 5.8 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
1.2 | 3.5 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
1.2 | 3.5 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
1.2 | 1.2 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
1.2 | 11.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
1.1 | 3.4 | GO:0004967 | glucagon receptor activity(GO:0004967) |
1.1 | 5.7 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
1.1 | 27.4 | GO:0030275 | LRR domain binding(GO:0030275) |
1.1 | 4.6 | GO:0051380 | norepinephrine binding(GO:0051380) |
1.1 | 9.1 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
1.1 | 3.4 | GO:0030957 | Tat protein binding(GO:0030957) |
1.1 | 20.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
1.1 | 4.5 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
1.1 | 10.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
1.1 | 6.8 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
1.1 | 14.6 | GO:0015250 | water channel activity(GO:0015250) |
1.1 | 7.9 | GO:0015232 | heme transporter activity(GO:0015232) |
1.1 | 25.4 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
1.1 | 3.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
1.1 | 5.4 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
1.1 | 4.3 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
1.1 | 10.9 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
1.1 | 4.3 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
1.1 | 3.2 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
1.1 | 3.2 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
1.1 | 25.8 | GO:0004402 | histone acetyltransferase activity(GO:0004402) peptide-lysine-N-acetyltransferase activity(GO:0061733) |
1.1 | 6.4 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
1.1 | 1.1 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
1.1 | 1.1 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) |
1.1 | 3.2 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
1.1 | 3.2 | GO:0061663 | NEDD8 ligase activity(GO:0061663) |
1.1 | 6.4 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
1.1 | 4.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
1.1 | 7.4 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
1.1 | 7.4 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
1.0 | 3.1 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
1.0 | 5.2 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
1.0 | 8.3 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
1.0 | 4.1 | GO:0051059 | NF-kappaB binding(GO:0051059) |
1.0 | 16.2 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
1.0 | 3.0 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
1.0 | 3.0 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
1.0 | 6.0 | GO:0039552 | RIG-I binding(GO:0039552) |
1.0 | 14.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
1.0 | 2.0 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
1.0 | 9.9 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
1.0 | 8.9 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
1.0 | 5.9 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
1.0 | 3.8 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
1.0 | 1.9 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
1.0 | 2.9 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
1.0 | 2.9 | GO:0004603 | phenylethanolamine N-methyltransferase activity(GO:0004603) |
1.0 | 5.7 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
1.0 | 3.8 | GO:0051425 | PTB domain binding(GO:0051425) |
1.0 | 1.9 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
1.0 | 7.6 | GO:0005534 | galactose binding(GO:0005534) |
1.0 | 8.6 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.9 | 4.7 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
0.9 | 9.3 | GO:0009374 | biotin binding(GO:0009374) |
0.9 | 1.9 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
0.9 | 1.9 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.9 | 3.7 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.9 | 2.8 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.9 | 9.2 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) phosphatidylinositol bisphosphate binding(GO:1902936) |
0.9 | 2.7 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
0.9 | 7.3 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
0.9 | 3.6 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.9 | 5.4 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.9 | 3.6 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.9 | 9.8 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.9 | 4.5 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.9 | 2.7 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.9 | 4.4 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.9 | 13.3 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.9 | 10.6 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.9 | 6.2 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.9 | 1.8 | GO:0005333 | norepinephrine transmembrane transporter activity(GO:0005333) |
0.9 | 3.5 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.9 | 18.4 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.9 | 5.3 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.9 | 25.3 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.9 | 4.4 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.9 | 6.1 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.9 | 2.6 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
0.9 | 1.7 | GO:0019981 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
0.8 | 13.6 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.8 | 11.0 | GO:0031996 | thioesterase binding(GO:0031996) |
0.8 | 23.7 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.8 | 15.2 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.8 | 5.9 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.8 | 2.5 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.8 | 21.4 | GO:0000976 | transcription regulatory region sequence-specific DNA binding(GO:0000976) |
0.8 | 5.7 | GO:0046790 | virion binding(GO:0046790) |
0.8 | 6.5 | GO:0004875 | complement receptor activity(GO:0004875) |
0.8 | 1.6 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.8 | 2.4 | GO:0032451 | demethylase activity(GO:0032451) |
0.8 | 16.9 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.8 | 0.8 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.8 | 3.2 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.8 | 90.1 | GO:0005179 | hormone activity(GO:0005179) |
0.8 | 2.4 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.8 | 2.4 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.8 | 7.9 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.8 | 6.3 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.8 | 3.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.8 | 2.3 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.8 | 3.8 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
0.8 | 19.9 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.8 | 3.0 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.8 | 6.1 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.8 | 12.9 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.8 | 1.5 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.7 | 5.2 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.7 | 8.2 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.7 | 3.0 | GO:0032810 | sterol response element binding(GO:0032810) |
0.7 | 5.9 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.7 | 2.2 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.7 | 1.5 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.7 | 3.6 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.7 | 7.3 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.7 | 2.9 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.7 | 2.2 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.7 | 2.2 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.7 | 12.9 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.7 | 5.7 | GO:0071253 | connexin binding(GO:0071253) |
0.7 | 12.1 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
0.7 | 2.8 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.7 | 2.1 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.7 | 16.3 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.7 | 3.5 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.7 | 0.7 | GO:0005124 | scavenger receptor binding(GO:0005124) |
0.7 | 0.7 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
0.7 | 2.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.7 | 3.5 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.7 | 20.1 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.7 | 3.5 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.7 | 6.2 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.7 | 2.1 | GO:0031711 | angiotensin type I receptor activity(GO:0001596) bradykinin receptor binding(GO:0031711) |
0.7 | 3.5 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.7 | 8.3 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.7 | 1.4 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.7 | 3.4 | GO:0070905 | serine binding(GO:0070905) |
0.7 | 4.1 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.7 | 36.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.7 | 5.4 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.7 | 2.0 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
0.7 | 18.2 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.7 | 4.0 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.7 | 7.4 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.7 | 18.2 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.7 | 2.0 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.7 | 6.0 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.7 | 4.0 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.7 | 2.0 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.7 | 2.0 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.7 | 4.6 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.7 | 3.9 | GO:0000987 | core promoter proximal region sequence-specific DNA binding(GO:0000987) |
0.7 | 9.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.7 | 2.0 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.6 | 3.2 | GO:0008142 | oxysterol binding(GO:0008142) |
0.6 | 1.9 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
0.6 | 3.2 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.6 | 1.3 | GO:0070052 | collagen V binding(GO:0070052) |
0.6 | 5.7 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.6 | 0.6 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.6 | 44.2 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.6 | 9.5 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.6 | 3.1 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.6 | 1.9 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.6 | 10.5 | GO:0070513 | death domain binding(GO:0070513) |
0.6 | 6.8 | GO:0043274 | phospholipase binding(GO:0043274) |
0.6 | 55.3 | GO:0005254 | chloride channel activity(GO:0005254) |
0.6 | 1.8 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
0.6 | 10.8 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.6 | 3.0 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.6 | 1.2 | GO:0005151 | interleukin-1, Type II receptor binding(GO:0005151) |
0.6 | 2.4 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.6 | 2.9 | GO:0043532 | angiostatin binding(GO:0043532) |
0.6 | 9.4 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.6 | 9.9 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.6 | 11.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.6 | 3.4 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.6 | 13.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.6 | 6.2 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.6 | 4.5 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.6 | 0.6 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.6 | 9.5 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.6 | 14.0 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.6 | 1.1 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.6 | 60.9 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.6 | 2.2 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
0.6 | 2.8 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.6 | 3.9 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.6 | 2.8 | GO:0039706 | co-receptor binding(GO:0039706) |
0.5 | 1.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.5 | 2.2 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.5 | 4.9 | GO:0032052 | bile acid binding(GO:0032052) |
0.5 | 6.0 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.5 | 2.7 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.5 | 9.2 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.5 | 3.3 | GO:0005119 | smoothened binding(GO:0005119) |
0.5 | 3.8 | GO:0005497 | androgen binding(GO:0005497) |
0.5 | 2.1 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.5 | 1.6 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.5 | 1.6 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.5 | 1.1 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.5 | 11.7 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.5 | 3.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.5 | 29.0 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.5 | 3.2 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.5 | 3.7 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.5 | 2.6 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.5 | 0.5 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.5 | 11.3 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.5 | 1.5 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.5 | 4.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.5 | 1.5 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.5 | 5.6 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.5 | 7.6 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.5 | 21.3 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.5 | 3.5 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.5 | 2.0 | GO:0032564 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
0.5 | 2.0 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.5 | 30.1 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.5 | 2.5 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.5 | 2.5 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.5 | 6.4 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.5 | 1.0 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.5 | 9.8 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.5 | 1.4 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
0.5 | 2.4 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.5 | 9.1 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.5 | 1.9 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.5 | 8.1 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.5 | 1.0 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.5 | 3.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.5 | 24.1 | GO:0070888 | E-box binding(GO:0070888) |
0.5 | 2.8 | GO:0034618 | arginine binding(GO:0034618) |
0.5 | 2.8 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
0.5 | 1.4 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.5 | 5.6 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.5 | 3.7 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.5 | 1.9 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
0.5 | 138.5 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.5 | 3.7 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.5 | 3.7 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.5 | 0.5 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.5 | 12.7 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.5 | 0.9 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.5 | 2.7 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.5 | 1.4 | GO:0019961 | interferon binding(GO:0019961) |
0.4 | 13.0 | GO:0009975 | cyclase activity(GO:0009975) |
0.4 | 2.2 | GO:0004359 | glutaminase activity(GO:0004359) |
0.4 | 5.8 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.4 | 1.3 | GO:0004756 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
0.4 | 7.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.4 | 6.6 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.4 | 1.3 | GO:0004802 | transketolase activity(GO:0004802) |
0.4 | 3.5 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.4 | 0.9 | GO:0004040 | amidase activity(GO:0004040) |
0.4 | 37.6 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.4 | 1.7 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.4 | 11.2 | GO:0005521 | lamin binding(GO:0005521) |
0.4 | 18.3 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.4 | 4.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.4 | 13.5 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.4 | 3.2 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.4 | 3.6 | GO:0035326 | enhancer binding(GO:0035326) |
0.4 | 10.8 | GO:0042805 | actinin binding(GO:0042805) |
0.4 | 6.0 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.4 | 30.7 | GO:0017022 | myosin binding(GO:0017022) |
0.4 | 1.2 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
0.4 | 2.0 | GO:0098988 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) group II metabotropic glutamate receptor activity(GO:0001641) G-protein coupled glutamate receptor activity(GO:0098988) |
0.4 | 2.0 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.4 | 152.7 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.4 | 7.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.4 | 1.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.4 | 3.9 | GO:0098960 | postsynaptic neurotransmitter receptor activity(GO:0098960) |
0.4 | 4.6 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.4 | 0.8 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.4 | 0.8 | GO:0035673 | oligopeptide transporter activity(GO:0015198) oligopeptide transmembrane transporter activity(GO:0035673) |
0.4 | 1.9 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.4 | 1.5 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.4 | 1.1 | GO:0016992 | lipoate synthase activity(GO:0016992) radical SAM enzyme activity(GO:0070283) |
0.4 | 1.5 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.4 | 1.5 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) sugar-phosphatase activity(GO:0050308) |
0.4 | 2.2 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.4 | 1.5 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.4 | 18.0 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.4 | 2.5 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
0.4 | 2.9 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.4 | 14.7 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.4 | 9.6 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.4 | 6.0 | GO:0033558 | histone deacetylase activity(GO:0004407) protein deacetylase activity(GO:0033558) |
0.4 | 0.4 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.3 | 3.8 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.3 | 4.2 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.3 | 0.7 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.3 | 1.4 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.3 | 7.6 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.3 | 2.4 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.3 | 1.4 | GO:0008518 | reduced folate carrier activity(GO:0008518) methotrexate transporter activity(GO:0015350) |
0.3 | 11.1 | GO:0005109 | frizzled binding(GO:0005109) |
0.3 | 4.0 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.3 | 0.7 | GO:1904680 | peptide transporter activity(GO:0015197) peptide transmembrane transporter activity(GO:1904680) |
0.3 | 3.3 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.3 | 2.3 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.3 | 2.6 | GO:0005112 | Notch binding(GO:0005112) |
0.3 | 4.8 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.3 | 3.2 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.3 | 1.0 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
0.3 | 0.9 | GO:0035671 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) enone reductase activity(GO:0035671) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.3 | 3.5 | GO:0050700 | CARD domain binding(GO:0050700) |
0.3 | 1.6 | GO:0030553 | cGMP binding(GO:0030553) |
0.3 | 0.9 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.3 | 1.2 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
0.3 | 16.5 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.3 | 0.9 | GO:0099609 | microtubule lateral binding(GO:0099609) |
0.3 | 0.9 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.3 | 61.3 | GO:0001012 | RNA polymerase II regulatory region DNA binding(GO:0001012) |
0.3 | 9.7 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.3 | 4.1 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.3 | 0.9 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.3 | 1.2 | GO:0015926 | glucosidase activity(GO:0015926) |
0.3 | 10.7 | GO:0043621 | protein self-association(GO:0043621) |
0.3 | 6.3 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.3 | 12.1 | GO:0001047 | core promoter binding(GO:0001047) |
0.3 | 6.9 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.3 | 4.0 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.3 | 1.1 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.3 | 1.7 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.3 | 7.6 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.3 | 4.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.3 | 10.9 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.3 | 0.3 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.3 | 5.7 | GO:0005272 | sodium channel activity(GO:0005272) |
0.3 | 3.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.3 | 1.1 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.3 | 1.1 | GO:0042019 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
0.3 | 1.3 | GO:0070728 | leucine binding(GO:0070728) |
0.3 | 5.4 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.3 | 2.4 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.3 | 6.4 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.3 | 2.4 | GO:0015643 | toxic substance binding(GO:0015643) |
0.3 | 0.3 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
0.3 | 1.6 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.3 | 0.3 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.3 | 0.5 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
0.3 | 2.5 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.3 | 6.3 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.3 | 17.9 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.3 | 0.8 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.2 | 3.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.2 | 0.5 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.2 | 0.2 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.2 | 2.0 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 22.9 | GO:0008201 | heparin binding(GO:0008201) |
0.2 | 24.3 | GO:0008083 | growth factor activity(GO:0008083) |
0.2 | 4.7 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.2 | 0.7 | GO:0017130 | poly(C) RNA binding(GO:0017130) |
0.2 | 2.6 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.2 | 0.5 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.2 | 4.8 | GO:0019840 | isoprenoid binding(GO:0019840) |
0.2 | 0.9 | GO:0016211 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
0.2 | 1.6 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 0.2 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.2 | 0.7 | GO:0016215 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.2 | 1.3 | GO:0035197 | siRNA binding(GO:0035197) |
0.2 | 4.3 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.2 | 0.6 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.2 | 17.5 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 0.8 | GO:0032145 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
0.2 | 0.4 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.2 | 0.6 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.2 | 1.6 | GO:0010181 | FMN binding(GO:0010181) |
0.2 | 1.2 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.2 | 3.7 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 0.4 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
0.2 | 4.3 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.2 | 0.6 | GO:0005549 | odorant binding(GO:0005549) |
0.2 | 16.1 | GO:0005178 | integrin binding(GO:0005178) |
0.2 | 1.0 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.2 | 7.0 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.2 | 0.8 | GO:0016499 | orexin receptor activity(GO:0016499) |
0.2 | 0.6 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.2 | 0.9 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.2 | 2.0 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.2 | 3.1 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.2 | 9.1 | GO:0000149 | SNARE binding(GO:0000149) |
0.2 | 1.8 | GO:0043495 | protein anchor(GO:0043495) |
0.2 | 2.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.2 | 2.9 | GO:0008143 | poly(A) binding(GO:0008143) |
0.2 | 0.3 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.2 | 0.7 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 5.5 | GO:0005518 | collagen binding(GO:0005518) |
0.2 | 0.8 | GO:0002046 | opsin binding(GO:0002046) |
0.2 | 0.5 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.2 | 0.3 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.2 | 2.5 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.2 | 0.3 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.2 | 0.9 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.2 | 4.5 | GO:0004713 | protein tyrosine kinase activity(GO:0004713) |
0.2 | 5.7 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.2 | 1.4 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.1 | 0.4 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 0.1 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 0.3 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.1 | 0.6 | GO:0019826 | oxygen sensor activity(GO:0019826) |
0.1 | 0.4 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
0.1 | 2.5 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 1.2 | GO:0019213 | deacetylase activity(GO:0019213) |
0.1 | 0.9 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.1 | 0.9 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 0.6 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.1 | 2.5 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 0.3 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 0.5 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 2.0 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.2 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.1 | 9.1 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 1.6 | GO:0008227 | G-protein coupled amine receptor activity(GO:0008227) |
0.1 | 1.8 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 38.0 | GO:0004888 | transmembrane signaling receptor activity(GO:0004888) |
0.1 | 0.3 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.1 | 0.8 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.1 | 1.2 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.6 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.1 | 0.4 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 0.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 1.8 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 1.2 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.1 | 0.5 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 0.2 | GO:0051766 | inositol trisphosphate kinase activity(GO:0051766) |
0.1 | 1.1 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 0.7 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.1 | 3.2 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 0.5 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.1 | 0.4 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.1 | 1.4 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 1.1 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 0.2 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.1 | 0.5 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 1.8 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 1.0 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 0.2 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.1 | 0.2 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.1 | 1.3 | GO:0015144 | carbohydrate transmembrane transporter activity(GO:0015144) carbohydrate transporter activity(GO:1901476) |
0.0 | 0.3 | GO:0052655 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.0 | 0.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.0 | 0.1 | GO:0047708 | biotinidase activity(GO:0047708) |
0.0 | 1.3 | GO:0016410 | N-acyltransferase activity(GO:0016410) |
0.0 | 0.1 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.0 | 0.7 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.0 | 0.1 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.0 | 0.3 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.2 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.2 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.0 | 0.1 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
0.0 | 0.4 | GO:0030295 | protein kinase activator activity(GO:0030295) |
0.0 | 0.1 | GO:0003980 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) |
0.0 | 0.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.0 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.1 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.1 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.0 | 0.1 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.6 | 7.6 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
6.4 | 19.2 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
5.3 | 21.0 | PID S1P S1P3 PATHWAY | S1P3 pathway |
3.4 | 16.8 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
3.2 | 167.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
2.8 | 71.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
2.5 | 10.1 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
2.5 | 166.8 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
2.4 | 249.0 | PID IL4 2PATHWAY | IL4-mediated signaling events |
2.4 | 2.4 | PID S1P S1P2 PATHWAY | S1P2 pathway |
2.1 | 87.4 | ST GAQ PATHWAY | G alpha q Pathway |
2.0 | 2.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
1.9 | 7.4 | PID ALK2 PATHWAY | ALK2 signaling events |
1.8 | 80.3 | PID BCR 5PATHWAY | BCR signaling pathway |
1.7 | 13.8 | ST ADRENERGIC | Adrenergic Pathway |
1.7 | 36.2 | PID EPO PATHWAY | EPO signaling pathway |
1.6 | 52.2 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
1.6 | 115.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
1.6 | 12.9 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
1.6 | 20.9 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
1.6 | 43.0 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
1.6 | 17.2 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
1.6 | 23.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
1.5 | 3.0 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
1.5 | 3.0 | PID S1P S1P4 PATHWAY | S1P4 pathway |
1.4 | 101.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
1.4 | 5.5 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
1.3 | 19.0 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
1.3 | 5.0 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
1.2 | 8.6 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
1.2 | 30.5 | PID IL2 1PATHWAY | IL2-mediated signaling events |
1.2 | 6.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
1.2 | 27.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
1.2 | 9.3 | ST GA12 PATHWAY | G alpha 12 Pathway |
1.1 | 20.5 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
1.1 | 3.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
1.1 | 9.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
1.1 | 51.6 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
1.1 | 51.3 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
1.1 | 181.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
1.1 | 3.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
1.0 | 8.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
1.0 | 43.4 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
1.0 | 107.3 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.9 | 3.7 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.9 | 233.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.9 | 1.7 | ST STAT3 PATHWAY | STAT3 Pathway |
0.9 | 29.1 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.8 | 17.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.8 | 21.7 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.8 | 27.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.8 | 34.8 | PID BMP PATHWAY | BMP receptor signaling |
0.8 | 26.4 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.8 | 2.3 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.7 | 64.6 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.7 | 21.1 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.7 | 2.2 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.7 | 24.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.7 | 13.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.7 | 6.3 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.7 | 18.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.6 | 6.4 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.6 | 3.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.6 | 9.9 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.6 | 1.2 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.6 | 7.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.6 | 7.4 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.6 | 4.6 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.6 | 41.9 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.6 | 30.7 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.5 | 2.2 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.5 | 30.7 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.5 | 3.7 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.5 | 26.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.5 | 7.6 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.5 | 7.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.5 | 21.7 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.5 | 6.8 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.5 | 9.8 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.5 | 19.4 | PID ARF6 PATHWAY | Arf6 signaling events |
0.5 | 3.9 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.5 | 3.4 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.5 | 9.6 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.5 | 12.9 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.5 | 12.3 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.5 | 10.8 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.5 | 24.1 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.5 | 6.0 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.4 | 11.6 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.4 | 5.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.4 | 2.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.4 | 0.8 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.4 | 1.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.4 | 2.2 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.4 | 13.0 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.3 | 2.3 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.3 | 9.2 | PID ENDOTHELIN PATHWAY | Endothelins |
0.3 | 3.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.3 | 5.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.3 | 5.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.3 | 10.6 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 4.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 3.0 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 4.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 6.3 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.2 | 3.1 | PID NOTCH PATHWAY | Notch signaling pathway |
0.2 | 4.1 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.2 | 1.5 | PID SHP2 PATHWAY | SHP2 signaling |
0.2 | 3.7 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 2.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 6.1 | PID ATM PATHWAY | ATM pathway |
0.1 | 3.7 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 1.1 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 3.5 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 0.5 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 0.9 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 1.1 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 0.5 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 0.7 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 0.5 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 3.1 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 1.9 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 1.3 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.4 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.7 | PID P53 REGULATION PATHWAY | p53 pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
11.6 | 266.8 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
6.7 | 67.4 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
6.4 | 133.5 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
4.6 | 18.4 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
4.1 | 12.4 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
3.8 | 30.0 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
3.7 | 59.7 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
3.4 | 269.8 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
3.3 | 56.7 | REACTOME DEFENSINS | Genes involved in Defensins |
3.2 | 9.7 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
3.2 | 79.1 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
3.0 | 6.1 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
2.7 | 37.9 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
2.5 | 44.1 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
2.4 | 7.3 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
2.4 | 26.6 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
2.3 | 48.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
2.3 | 22.6 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
2.3 | 27.0 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
2.2 | 47.0 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
2.2 | 37.2 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
2.1 | 27.3 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
1.9 | 83.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
1.9 | 28.6 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
1.8 | 30.2 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
1.7 | 1.7 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
1.7 | 5.0 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
1.6 | 1.6 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
1.5 | 15.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
1.5 | 13.8 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
1.4 | 7.2 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
1.4 | 45.2 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
1.4 | 1.4 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
1.4 | 47.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
1.3 | 9.4 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
1.3 | 14.6 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
1.3 | 50.0 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
1.3 | 20.7 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
1.3 | 18.0 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
1.3 | 81.0 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
1.3 | 56.3 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
1.2 | 38.5 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
1.2 | 9.9 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
1.2 | 12.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
1.2 | 14.4 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
1.2 | 8.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
1.1 | 60.6 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
1.1 | 23.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.0 | 29.4 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
1.0 | 13.6 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
1.0 | 19.4 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
1.0 | 48.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
1.0 | 16.5 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
1.0 | 9.7 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
1.0 | 20.4 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
1.0 | 116.1 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.9 | 1.9 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.9 | 6.6 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.9 | 14.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.9 | 22.2 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.9 | 4.6 | REACTOME PI3K AKT ACTIVATION | Genes involved in PI3K/AKT activation |
0.9 | 25.2 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.9 | 8.0 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.9 | 2.6 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.9 | 7.1 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.9 | 58.8 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.9 | 17.3 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.8 | 22.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.8 | 7.5 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.8 | 26.9 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.8 | 4.0 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.8 | 20.5 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.8 | 44.8 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.8 | 32.9 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.8 | 4.6 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.8 | 8.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.8 | 6.1 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.7 | 9.0 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.7 | 15.6 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.7 | 13.1 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.7 | 19.0 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.7 | 25.8 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.7 | 10.4 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.7 | 26.5 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.7 | 1.3 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.7 | 3.3 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.6 | 9.1 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.6 | 12.8 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.6 | 10.9 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.6 | 53.8 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.6 | 8.8 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.6 | 11.8 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.6 | 12.9 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.6 | 6.1 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.6 | 1.2 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
0.6 | 6.5 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.6 | 52.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.6 | 6.9 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.6 | 9.1 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.6 | 29.3 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.6 | 20.2 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.5 | 0.5 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.5 | 8.0 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.5 | 1.0 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.5 | 10.9 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.5 | 14.2 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.5 | 123.7 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.5 | 2.8 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.5 | 74.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.5 | 8.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.5 | 9.2 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.5 | 3.2 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.5 | 14.2 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.5 | 3.7 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.5 | 3.7 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.4 | 2.2 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.4 | 17.6 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.4 | 1.7 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.4 | 4.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.4 | 4.6 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.4 | 11.2 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.4 | 5.0 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.4 | 7.4 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.4 | 28.1 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.4 | 2.4 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.4 | 11.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.4 | 5.6 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.4 | 10.9 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.4 | 6.7 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.4 | 1.1 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.4 | 7.1 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.4 | 4.9 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.3 | 3.6 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.3 | 5.9 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.3 | 16.7 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.3 | 8.8 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.3 | 6.8 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.3 | 9.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.3 | 15.2 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.3 | 18.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.3 | 3.2 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.3 | 26.8 | REACTOME GPCR LIGAND BINDING | Genes involved in GPCR ligand binding |
0.3 | 6.8 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.3 | 5.7 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.3 | 0.6 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.3 | 41.8 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.3 | 1.3 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.3 | 3.8 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.2 | 1.0 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.2 | 0.6 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 1.9 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.2 | 2.2 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.2 | 2.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.2 | 0.6 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.2 | 2.8 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 4.2 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.3 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 2.0 | REACTOME PI3K EVENTS IN ERBB4 SIGNALING | Genes involved in PI3K events in ERBB4 signaling |
0.1 | 1.1 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.1 | 2.0 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 0.1 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 23.6 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.1 | 3.4 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 4.0 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 1.1 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.1 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.0 | 1.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.3 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 0.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 0.3 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.0 | 0.2 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.0 | 0.4 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.3 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 0.2 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.0 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
0.0 | 1.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.3 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |